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Inadequate transfer of passive immunity (ITPI) 
The immunity of neonatal calves depends almost entirely on the absorption of maternal 
immunoglobulins (Ig) and other immunity components from the colostrum following birth. In fact, 
ruminants have a synepitheliochorial placenta that does not allow the transfer of Ig and other 
immunity components during fetal life. The term failure of passive transfer (FPT) or inadequate 
transfer of passive immunity (ITPI) indicates a pathological condition where the calf did not absorb 
enough passive immunity1. The minimum cut-off for an adequate immunity passive transfer is set 
at 10 g/L of IgG serum concentration in the first 6 days of life2,3. Therefore calves with a 
concentration of IgG lower than 10 g/L are considered affected by ITPI4. The prevalence of ITPI 
in dairy calves is estimated to be about 19%5.  
The cost per calf affected by ITPI is estimated at €60 (95% prediction interval: €10- €109) in dairy 
herds and €80 in beef animals (95% prediction interval: €12 - €131)6. The economic damage caused 
by ITPI derives from the associated consequences of this condition. The consequences of ITPI 
have been shown to increase both the risk of mortality, especially during the first month of life, and 
neonatal morbidity, as well as diarrhea and respiratory diseases and reduce calf growth rate6. In 
addition, ITPI in heifer calves affects long-term productivity. Low IgG levels have been associated 




Bovine colostrum is composed by proteins such as Ig, lactoferrin, transferrin, albumin, α-
lactalbumin and β-lactoglobulin; fat, carbohydrates, water, fat soluble vitamins; electrolytes, 
cytokines and growth factors such as lysozyme, lactoperoxidase, insulin, growth factor beta-2, 
growth hormone, insulin-like growth factor-I. The concentration of these components is higher in 
the first lacteal secretion (first milking colostrum) compared to the next six ones (transition milk). 
High-quality colostrum is defined as such when IgG concentration is greater than 50g/L, total 
bacteria count is less than 100000 cfu/ml and total coliform count is less than 1000 cfu/ml12. 
Immunoglobulins  
IgG, IgA, and IgM account for approximately 85% to 90%, 5%, and 7%, respectively, of the total 
Ig in the colostrum30. IgG are transferred from the bloodstream across the mammary barrier into 
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the colostrum by a specific transport mechanism: Receptors on the mammary alveolar epithelial 
cells capture IgG from the extracellular fluid, and the molecules undergoes endocytosis, transport, 
and finally released into the luminal secretions30. The alveolar epithelial cells cease expressing this 
receptor, most likely in response to increasing prolactin concentrations, at the onset of lactation1. 
Smaller amounts of IgA and IgM are largely derived from local synthesis by plasmacytes in the 
mammary gland30.  
Maternal leukocytes 
Normal bovine colostrum contains greater than 1 x 106 cells/mL of immunologically active 
maternal leukocytes, including macrophages, T and B lymphocytes, and neutrophils 30. At least a 
portion of colostral leukocytes are absorbed still intact across the intestinal barrier. Although their 
functional importance in calves is not routinely measured, early evidence suggests that colostral 
leukocytes enhance lymphocyte response to nonspecific mitogens, increase phagocytosis and 
bacterial killing ability, and stimulate humoral immune responses (IgG formation) in the calf30. 
Cytokines and growth factors 
Other important components of colostrum include growth factors, hormones, cytokines, and 
nonspecific antimicrobial factors. Bioactive components of colostrum with antimicrobial activity 
include lactoferrin, lysozyme, and lactoperoxidase. Oligosaccharides in colostrum may provide 
protection against pathogens by acting as competitive inhibitors for the binding sites on the 
epithelial surfaces of the intestine. Growth factors in bovine colostrum include transforming 
growth factor beta-2 (TGF-b2), growth hormone (GH), and insulin, but their function in 
colostrum is not fully understood. Colostral insulin-like growth factor-I (IGF-I) may be a key 
regulator in the development of gastrointestinal tracts of bovine neonates, including stimulation of 
mucosal growth, brush-border enzymes, intestinal DNA synthesis, increased villus size, and 
increased glucose uptake. Trypsin inhibitor, a compound found in colostrum in concentrations 
nearly 100 times greater than in milk, serves to protect IgG and other proteins from proteolytic 
degradation in the intestine of the neonatal calf12. 
Nutrients 
The total solids content (%) in first milking colostrum and whole milk in Holstein cows has been 
reported to average 23.9% and 12.9%, respectively. Much of this increase in colostrum solids 
content is attributed to a more than fourfold increase in protein content of colostrum versus milk, 
this being because of significant increases in Ig and casein content15. The crude fat content of first 
milking Holstein colostrum (6.7%) is also significantly higher than for milk (3.6%)5. Energy from 
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fat and lactose in colostrum is critical for thermogenesis and body temperature regulation. Certain 
vitamins and minerals, including calcium, magnesium, zinc, manganese, iron, cobalt, vitamin A, 
vitamin E, carotene, riboflavin, vitamin B12, folic acid, choline, and selenium are also found in 
increased concentrations in bovine colostrum versus milk12.  
 
Risk factors of ITPI 
The risk factors for the ITPI are mostly of a managerial character. In fact, the timing of colostrum 
ingestion as well as the method and volume of the colostrum administration are the most important 
risk factors for ITPI9.  
The absorption of Ig in new-born calves occurs through enterocyte non-selective pinocytosis. The 
efficiency of absorption declines during the first 24 hours of life 10,11. During this period, the 
intestine is defined “open gut”12. The efficiency of Ig transfer across the gut epithelium is optimal 
during the first 4 hours postpartum, but after 6 hours there is a progressive decline in the efficiency 
of Ig absorption over time13,14. Delaying the first colostrum feed can only slightly postpone gut 
closure (36 hours)11. Feeding colostrum after the gut has closed still offers the benefits of local 
immunity in the gut lumen, but Ig absorption into the circulation no longer occurs12.  
In addition to the time of colostrum administration, the volume of ingested colostrum also 
influences the correct passage of passive immunity12. To achieve successful passive transfer in a 
Holstein calf, experts calculated that calves must ingest at least a minimum mass of 100 g of IgG 
through colostrum15. Therefore, the volume of colostrum to be administered depends on its IgG 
concentration. Frequently though, the colostrum IgG concentration is not known. Some studies 
have demonstrated that feeding the calf 10% to 12% of its body weight reduces the risk of failure 
of passive immunity transfer2.  
Also the method used when feeding colostrum can indirectly influence the absorption of passive 
immunity; it influences both the volume of colostrum consumed and the time it takes for the calf 
to feed. High rates of failure of passive transfer have been reported in calves left to suckle the 
dam2,16. This finding may be attributable to the failure of the calf to voluntarily consume a sufficient 
volume of colostrum and delays in suckling12. These delays could be caused by numerous factors 
and it is currently recommended that the calf is removed from the dam within 1 to 2 hours of birth, 
and that the calf should be hand-fed a known volume of colostrum using either a nipple bottle or 
an esophageal feeder17. It is generally accepted that either method of feeding achieves acceptable 
rates of passive transfer provided a sufficient volume of colostrum is consumed18,19. Veterinarians 
 6 
should train interested producers on how to properly use and clean esophageal feeders in order to 
avoid iatrogenic damage such as aspiration pneumonia or pharyngeal perforation20.  
However, ITPI may occur even under ideal conditions because some risk factors do not depend 
on management. Indeed, the immunoglobulin concentration of the colostrum ingested and the age 
of the dam influence the correct transfer of passive immunity but they are not easy to check in 
advance9. Also the birth season can increase the likelihood of developing FTP. Some studies have 
shown that in temperate climates the serum IgG concentration is at its highest in summer and 
lowest in winter21-23. While in semi-tropical climates the lowest IgG concentration is observed 
during summer. The possible explanation is that greater environmental stress (cold in temperate 
climates and heat in semi-tropical climates) could influence the quality and absorption of colostrum 
immunity24.  
Another factor that increases the risk of ITPI is difficult calving25. Acidosis in calves following 
dystocia or forced extraction may be due to premature rupture of the umbilical vessels or irregular 
respiration after birth, which may lead to reduced vitality. This condition can affect the suckling 
reflex and standing time which have been assessed as objective behavioral indicators of fetal stress 
in calves. Increased standing time has been found to be associated with a reduced or delayed 
motivation to drink colostrum after birth and consequently with a higher incidence of ITPI. In 
calves with fetal distress, consumption of colostrum is reduced by 74% during the first 12 h after 
birth26. In one study, acidosis (venous blood pH of 7.15) was associated with a 52% decrease in 
colostrum intake and a 35% decrease in serum IgG concentration compared to calves with venous 
blood pH > 7.2527. In other studies, acidosis was linked with high morbidity rate and ITPI rate. In 
these studies, the association between acidosis and ITPI was associated with reduced IgG 
absorption, rather than intake. Dystocia-induced hypoxia, hypercapnia, and respiratory acidosis 
have been associated with decreased absorption of IgG28.  
In conclusion, the risk factors for ITPI are in most cases associated with colostrum management, 
but there are some individual factors that can predispose to ITPI. The most important of these 
factors are associated with the effect of dystocia on physiological and behavior characteristics in 
new-born calves. Therefore, to control the risk factors for ITPI it is fundamental to educate the 
farmers on colostrum management, develop a colostrum monitoring program to quickly identify 
and correct problems and limit the effects of dystocia through an efficient delivery assistance which 




Diagnosis of ITPI 
Following the deep understanding of the relationship between Ig concentrations and calf health, it 
is widely recognised that colostrum contains a wide spectrum of important immune and nutritional 
components. This, together with the fact that IgG compose more than 85% of total 
immunoglobulins in colostrum, means that traditionally IgG in colostrum have been considered 
the hallmark for evaluating colostrum quality [6]. In fact, as previously mentioned, serum IgG 
concentrations in new-born calves are directly associated with the amount of colostrum absorbed, 
meaning that the quality of immune passive transfer can be assessed using serum IgG 
concentrations during the first days of life.  
ITPI occurs when the serum IgG concentration is less than 10 g/L5,12,29. The serum IgG levels are 
generally evaluated because they represent the most abundant fraction of Ig30. For the diagnosis of 
ITPI many tests have been developed. The gold standard method for assessing the status of passive 
transfer in calves is to measure immunoglobulin levels in the serum. IgG is quantified by radial 
immunodiffusion (RID) or enzyme-linked immunosorbent assay (ELISA)9. However, these 
methods are expensive and require laboratory analysis, therefore they are not commonly used in 
field conditions 31,32. Hence, in the field, more practical tests for ITPI are usually used 33(5). Among 
these tests, the evaluation of serum total protein (sTP) is the easiest to perform in field conditions. 
The measurement of sTP was done using a handle refractometer as an estimate of serum 
immunoglobulin concentrations. sTP measurement by handle refractometer was demonstrated to 
have a good correlation with IgG concentrations 54. The sensitivity and specificity depended on 
the cut-off points chosen. The most used cut-off points were 52 g/L and 55 g/L. In a recent 
metanalysis, the results for the first cut-off had a sensitivity of 76,1% and a specificity of 89,3%, 
while for the second of 55 g/L, the sensitivity was 88,2%, and the specificity was 77,9%. The 
literature suggests using 55g/L as a cut-off point in clinically ill calves to provide a reasonably 
accurate assessment of the passive transfer status34. With a healthy, adequately hydrated calf, a 
serum total protein of 52 g/L or greater is associated with adequate passive transfer35. 
A similar method to estimate the IgG concentration is with the BRIX refractometer. This test is 
more practical and easier to perform in field conditions. When using the BRIX refractometer, the 
results obtained from the serum reading were correlated with the concentration of IgG. The study 
determined that BRIX values ≤8.5% correspond to a concentration ≤10 g/L IgG (sensitivity 
100%, specificity 89.2), therefore the results from the handle and BRIX refractometer overlap 
(handle refractometer sensitivity 100%, specificity 80,4%)36.  
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Another indirect test to diagnose ITPI is the measurement of the enzyme Gamma-Glutamyl-
Transferase (GGT). GGT is produced by the ductile cells of the mammary gland and as a result it 
is found in colostrum37. In calves that have ingested colostrum, serum GGT concentrations will be 
high compared to those of adult cows38-40. GGT was found to rise quickly after the ingestion of 
colostrum. A precipitous decrease in activity was seen over the next 24 hours followed by a more 
gradual decline over the next 2 months. Based on these findings, serum GGT activity increased in 
neonatal calves as a result of the ingestion of colostrum therefore their concentration is used as a 
method to diagnose ITPI. The GGT cut-off, to establish if calves are affected by ITPI, changes 
according to the age of the animals. In 1-day-old calves with adequate passive transfer, serum GGT 
activity should be [1]200 IU/L. In 4-day-old calves with adequate passive transfer, serum GGT 
activity should be [1]100 IU/L. In 1-week-old calves with adequate passive transfer, serum GGT 
activity should be [1]75 IU/L. Calves that have serum GGT activity 50 IU/L within the first 2 
weeks of life should be considered to have ITPI. Quantification of GGT concentration in field 
conditions is more difficult than using a refractometer to determine the concentration of sTP, 
therefore it is not used routinely in the field. 
Another test to diagnose ITPI is the whole-blood glutaraldehyde coagulation test. Initially, this test 
was introduced as a method to detect hypergammaglobulinemia in adult cattle41. This test takes 
advantage of the fact that uncharged amino groups on proteins will form cross-linkages with 
aldehyde groups forming a visible clot41. The glutaraldehyde coagulation test was used to estimate 
gamma-globulin concentrations in neonatal calves. This method used serum as opposed to whole 
blood, eliminating the potential interaction of fibrinogen. To determine immunity passive transfer 
50 µL of 10% glutaraldehyde is added to 0.5 mL of serum. The samples then were observed for 
one hour to assess clot formation. Samples with no clot formation within the hour were considered 
agammaglobulinemic. The whole-blood glutaraldehyde clot test has recently been marketed for use 
in calves. To perform this test, 1.5 mL of whole blood is added to a pre-prepared glutaraldehyde 
solution and the time necessary for the clot to form is recorded. Clot formation in <5 minutes is 
indicative of adequate passive transfer. The sensitivity and specificity of the test were endpoint-
dependent, with sensitivity ranging from 0.41 to 0.00 and specificity ranging from 0.85 to 1.00. The 
very low sensitivity of the test makes it not recommended for routine use, even if it can be used in 
field conditions.  
Other indirect tests are the sodium sulfite turbidity test and the zinc sulfate turbidity test. 
The sodium sulfite turbidity test is a 3-step semiquantitative test using 14, 16, and 18% sodium 
sulfite test solutions42. The test solutions cause selective precipitation of high molecular weight 
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proteins, including immunoglobulins. This precipitation results in turbidity, which is the measured 
endpoint. Increasing concentrations of reagent or salt solution will induce turbidity at lower 
concentrations of high molecular weight proteins. Consequently, turbidity using a 14% test 
solution is indicative of higher serum immunoglobulin concentrations than turbidity using a 16% 
test solution. Similarly, turbidity using a 16% test solution is indicative of higher serum 
immunoglobulin concentrations compared to turbidity using a 18% test solution. The 18% 
endpoint had a lower sensitivity, 0.85, than the 16% and 14% endpoints, which both had a 
sensitivity of 1.0. However, the 18% endpoint had a dramatically better specificity of 0.87 versus 
0.56 and 0.03 for the 16% and 14% endpoints. Consequently, optimal diagnostic utility is attained 
using an 18% test solution.  
The zinc sulfate turbidity test operates on the same basic principle as the sodium sulfite turbidity 
test. This is typically performed as single dilution assay in which 0.1 mL of serum is added to 6 mL 
of 208 mg/L zinc sulfate solution. The assay is allowed to incubate at room temperature for 30 
minutes and turbidity is recorded. At this dilution, the test has an inappropriately high endpoint, 
which was demonstrated by Tyler et al35. At this concentration, the test demonstrated a very poor 
specificity of 0.52 and only correctly classified 69% of the calves tested. Other major limitations of 
this test are the effect of hemolysis and the fact that the solutions are not stable when exposed to 
atmospheric carbon dioxide35,43,44.  
These tests are not suitable for field use as they are more expensive compared to other methods 
and harder to perform without increasing the sensitivity and specificity of the test. 
In conclusion, the gold standard for diagnosing is using the direct test such as RID or ELISA, 
however in field conditions the sTP concentration is the best indirect method to identify calves 
affected by ITPI in an easy, economical and fast way. 
  
Treatment of ITPI 
New-born calves are agammaglobulinemic at birth. However, they are immunocompetent and 
produce approximately 1 g IgG1 per day45. Despite the production of endogenous antibodies, the 
immune system of calves does not become fully mature until 5 to 8 months of age. Therefore, 
although calves suffering from ITPI are at a greater risk for developing disease, they can survive if 
they are placed in a clean environment with low exposure to infectious pathogens. 
The decision to treat a calf with ITPI should be based on several factors including its age, value 
and surrounding environment. 
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Plasma transfusion has been empirically recommended as a treatment in calves with ITPI9,34 and 
has been used successfully in primary or supportive therapy of many equine diseases46. In cattle, 
data regarding the efficacy and safety of plasma transfusions are limited. Whole blood can also be 
used, but the dosage should be increased to account for the presence of red blood cells.  
In literature, the use of plasma is only described in calves with experimental ITPI. In fact, in these 
studies a group of calves was experimentally deprived of colostrum and compared to calves who 
had been properly colostrated47-50. The values of plasma IgG concentration and their half-life are 
discordant in the different studies. In one study the plasma IgG concentration is less than 10 g/L, 
12 hours after plasma administration50. In another study the concentration of plasma IgG remained 
over 10 g/L during the observation period (1 week). Murphy et al.48 showed that plasma IgG half-
life is comparable to colostrum IgG half-life (respectively 27,3 and 28,5 days). In this study the 
development of NCD and mortality rates were significantly higher in calves that received plasma 
transfusion47-50. Only one study tested the efficacy of plasma transfusion in calves with spontaneous 
ITPI. In this study, the dosage of plasma (0,5 L) did not provide adequate serum IgG 
concentrations in neonatal calves with inadequate transfer of colostral immunoglobulins51. 
Therefore, the efficiency of plasma transfusion as a treatment in calves with ITPI is still unclear 
and further studies are needed to verify its therapeutic validity. In addition to plasma or whole-
blood transfusions, oral colostrum supplementation beyond the period of closure is logical to 
provide protection at a gut lumen level.  
Finally, the prophylactic use of broad-spectrum, parenteral antimicrobials in calves with ITPI is a 
rational consideration. However, the use of prophylactic antimicrobials must be combined with 
management practices that minimize pathogen exposure because antimicrobials will not neutralize 
the effects of a high pathogen load.  
  
Consequences of ITPI 
As mentioned above, ITPI can have serious consequences both in the neonatal period and in the 
long term. The most relevant consequence of ITPI is mortality and morbidity in the pre-weaning 
period52,53. In fact, in dairy herds, mortality linked to ITPI has been reported as ranging from 8 to 
25%54. Furthermore, the morbidity due to ITPI during the pre-weaning period is a well-accepted 
consequence, especially for neonatal calf diarrhea (NCD) and bovine respiratory disease (BRD) in 
dairy herds55,56. In Holstein Friesian calves affected by NCD it has been found that a low sTP levels 
are significantly associated with case fatality risk52. 
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In the post-weaning period, ITPI has been associated with a significant decrease in average daily 
gain compared to dairy heifers who’s passive transfer was adequate. Furthermore, heifers with ITPI 
also had higher mortality rates compared to those with adequate passive transfer57.  
Another consequence of ITPI are the long-term effects linked with production performance. 
Heifers with ITPI had significantly lower mature equivalent milk production during the 1st 
lactation and consequently had a greater tendency to be culled during the 1st lactation when 
compared to those with an adequate passive transfer7,8.  
In beef calves with ITPI an increased risk of both neonatal and pre-weaning mortality, as well as 
pre-weaning morbidity, was found when comparing them to calves with adequate passive transfer. 
In the feed lot, the productivity of calves with ITPI was lower with an increased risk of mortality 
and respiratory tract morbidity when compared to calves with adequate passive transfer58.  
The consequences in calves with ITPI are therefore linked to problems in both the growth and 
production periods. This increases breeding costs and reduces profits, making this condition an 




Neonatal Calf Diarrhea (NCD) 
Neonatal Calf Diarrhea (NCD) is a multifactorial disease, resulting from interaction among 
animals, their environment, nutrition and pathogens25,59. NCD causes economic loss due to 
mortality, treatment cost, poor growth and poor production60,61. A previous study reported that 
mortality risks for diarrhea ranged from 4,9% to 35% 53,62. Escherichia coli F5, Bovine Rotavirus, 
Bovine Coronavirus and Cryptosporidium spp. are the most important pathogens causing neonatal 
diarrhea in calves worldwide63-67. Sometimes there can be an infection from more than one 
pathogen that can occur either simultaneously or consecutively, resulting in an increase of the 
morbidity and mortality rates68. The immunity of the new-born calf is closely implicated in the 
pathogenesis and outcome of NCD. In fact, the relationship between ITPI and morbidity or 
mortality has been observed in many studies. 
 
Aetiology and pathogenesis of NCD 
NCD is a health challenge in both beef and dairy industries. More than 20% of beef cattle owners 
feel that calf diarrhea has a significant impact on their economic productivity59, as it accounts for 
more than half of all calf mortality on dairy farms25.  
Several factors affect NCD development; Calf management, especially calving management69, 
colostrum management25,70, calf housing and feeding71,72, farm size73 as well as hygiene59, have an 
important role on the calf’s health, and consequently in the NCD manifestation.  
Although the relationship between ITPI and mortality has been observed in many studies74,75, the 
influence of ITPI in the development of diarrhea is not clear76. Donovan et al.56 showed that sTP 
was not a significant risk factor for diarrhea and Berge et al.76 showed that adequate passive transfer 
had no specific influence on the number of days the calf manifested signs of diarrhea. Differently, 
Parè et al.70 showed that hematocrit and total protein may have an important prognostic value in 
estimating the risk of NCD. In a recent study calves with ITPI showed a 24 times higher risk of 
developing NCD than calves with adequate transfer of passive immunity55. IgG and sTP were not 
associated with the age of onset of diarrhea but a high IgG and a high sTP concentration were 
associated with a decreased length of each episode70. Moreover, ITPI calves had a 22% increased 
chance of being affected from diarrhea for more days compared to calves with adequate passive 
transfer25. However, evidence from literature confirms that calves with adequate transfer of passive 
immunity have significantly lower mortality and morbidity rates and consequently will receive 
fewer antimicrobial treatments76.  
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Another important factor that influences the development of NCD is nutrition. In fact, calves fed 
more than 10 to 12% of their body weight (BW) in milk have a better performance, whereas 
deficiencies in nutrition may lead to depressed immunity in calves and increased morbidity71.  
Calf housing and hygiene have a fundamental role in the manifestation of NCD. Cleaning the areas 
the calves are kept, in decreases the risk of diarrhea59. When cows are dirty, their calves are logically 
more at risk of illness. Removal of bedding is thought to eliminate a substantial portion of any fecal 
material harbouring infectious organisms. A poorly drained area is likely to support the survival of 
pathogens and to increase the amount of contamination of the area. Pathogens can survive in the 
environment for months or years in cool, wet conditions, and consequently both disease incidence 
and mortality can increase in permanently dirty calf housing59.  
Escherichia coli F5, Bovine Rotavirus, Bovine Coronavirus and Cryptosporidium parvum are the 
most important pathogens causing neonatal diarrhea in calves worldwide63-67. Sometimes, 
infections can be caused by different pathogens either simultaneously or consecutively, resulting in 
an increase of morbidity and mortality rates68. 
  
Escherichia coli 
The prevalence of E. coli in cases of NCD ranges between 2,6% and 45,1%. Therefore, E. coli is 
the most important bacterium involved in NCD, in particular E. coli F5 was isolated in 78,8% of 
NCD cases in calves younger than 7 days77. These bacteria produce the K99 adhesion antigen and 
heat-stable enterotoxin78. Following ingestion, E. coli F5 infects the intestinal epithelium and 
multiplies in the enterocytes of the intestinal villi in the distal portion of the small intestine63. This 
bacterium expresses the K99 antigen for attachment. Villous atrophy due to a loss of infected cells 
and damage to the lamina propria, are commonly observed in affected small intestines. After 
colonization of the epithelium, heat-stable toxin (STa) production induced by E. coli F5 leads to 
the up-regulation of chloride and bicarbonate secretion into the gut (Fig. 3). This osmotically draws 
water into the intestinal lumen and leads to the development of secretory diarrhea in calves79. 
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Fig.3. Frame 1: K99 ETEC binds to an intestinal epithelial cell, and a heat stable toxin (STa) is 
secreted, which binds to the receptor GCC. The enteric nervous system is activated by 
the secretion of STa, however the mechanism of this activation is unclear. At this point, CFTR is 
not active. Frame 2: STa binds to GCC, which converts guanylyl triphosphate (GTP) to 
cGMP. cGMP activates cGKII which phosphorylates the CFTR, and the CFTR moves to the luminal 
surface and is activated, leading to chloride (Cl) secretion. Frame 3: Secreted STa activates 
tyrosine kinase through an unknown pathway, which leads to bicarbonate (HCO3) secretion. 
STa also directly inhibits the sodium–hydrogen exchanger, decreasing the movement of sodium 
(Na) and hydrogen (H) across the membrane. 
 
Furthermore, lipopolysaccharides (LPS), a component of the gram-negative bacteria cell wall, are 
considered the primary virulence factor of all serotypes of E. coli. LPSs are released from the 
bacteria following cell death and during multiplication. The massive release of LPSs could cause 
endotoxin shock80, resulting in a worsening of clinical condition25,81.  
 
Bovine Rotavirus 
The prevalence of Bovine rotavirus in case of NCD ranges between 17,7% and 79,9%. Bovine 
Rotavirus causes diarrhea in calves of 1 to 2 weeks of age. Calves become infected after ingesting 
the virus from fecal contamination of the environment, as the virus is stable if temperatures remain 
above freezing. A milk-based diet predisposes to creating an ideal environment for viral replication 
and infection. The infected calves shed a large amount of virus in their faeces for 5-7 days, thus 
contaminating the environment and allowing the virus to be transmitted to other pen mates18. 
After ingesting the virus, the incubation period is approximately 24 hours, with resolution of 
diarrhea in 2 days for uncomplicated cases82. Classically, rotavirus diarrhea is thought to be 
primarily a malabsorptive diarrhea, but recent evidence indicates that there is also a toxin-mediated 
secretory component as well. The virus replicates in the cytoplasm of epithelial cells of the villi of 
the small intestine.  
 15 
The virus attaches to these cells via specific receptors and invades through an unknown mechanism. 
Malabsorption will then occur because of the loss of surface area, and unabsorbed glucose and 
other carbohydrates create an osmotic load drawing fluid into the lumen. Furthermore, fluid 
secretion from the crypts increases the amount of fluid in the intestinal lumen, exceeding the 
capacity of the villi to absorb it, which leads to diarrhea82-84. 
Rotavirus also causes secretory diarrhea following the activation of the enteric nervous system by 
vasoactive components derived from damaged cells and the secretion of viral enterotoxins such as 
NSP4. The enteric nervous system appears to play a critical role in rotavirus-induced secretion, but 
the mechanism responsible for this effect is unclear. Extracellular and intracellular exposure to 
NSP4 causes several changes in the movement of nutrients and water across the epithelium (Fig. 
4). 
  
Fig. 4. Once rotavirus replicates in an intestinal epithelial cell, the enterotoxin NSP4 is produced. 
It has autocrine effects by causing calcium (Ca) release from the endoplasmic reticulum. 
NSP4 has paracrine effects through its secretion and binding to caveolin-1. This activates 
PLC, which increases cytoplasmic IP3. IP3 increases intracellular calcium by increasing release 
from the endoplasmic reticulum and increasing calcium movement across the luminal membrane. 
The increased intracellular calcium inhibits movement of disaccharidases to the luminal 
surface. NSP4 directly inhibits SGLT1 which decreases the absorption of sodium (Na) 
and glucose, and increases chloride (Cl) secretion with an unknown mechanism, that could involve 
a channel created by NSP4. NSP4 also activates the enteric nervous system through an unknown 
mechanism. 
 
Increases in intracellular calcium inhibit the translocation of disaccharidases from the intra-cellular 
vesicles to the luminal surface, decreasing the ability to digest carbohydrates and leading to 
maldigestion and diarrhea exacerbation85,86111.  
Also, NSP4 directly inhibits sodium glucose cotransporter SGLT1, the primary sodium and 
glucose cotransporter that is critical for effective water absorption, significantly contributing to the 
pathogenesis of rotaviral diarrhea. The actions of NSP4 better account for the maldigestion and 
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malabsorption that are found in rotavirus diarrhea, therefore it is likely that NSP4 is more 
significant to the pathogenesis compared to histologic damage to the epithelium111. 
 
Bovine Coronavirus 
The prevalence of Bovine Coronavirus in case of NCD ranges between 3,1% and 21,6%. 
Coronavirus antibodies are ubiquitous in cattle, and the virus is frequently found in both normal 
and diarrheic calf feces87,88. This virus infects calves in the first 3 weeks of life. The virus is ingested 
from the environment, which is contaminated by other calves or adult cattle82. Clinical signs begin 
approximately 2 days post contamination and continue for 3 to 6 days89. Viral infection begins in 
the small intestine and usually spreads through the entire small intestine and colon. 
Microscopically, villi of the affected small intestine and colon crypts become atrophic, while the 
lamina propria becomes necrotic. Coronavirus replicates in enterocytes and progeny viruses are 
released through a normal secretory mechanism and cell lysis. Mature villous epithelial cells are the 
primary target of the virus although crypt enterocytes are also affected. Clinical signs in affected 
animals often last longer due to the damage done to enteric crypts by the virus90. 
 
Cryptosporidium parvum 
Cryptosporidium spp. is frequently involved in NCD (prevalence 27,8% - 58,5%) and it affects 
calves at 2 weeks of life77. C. parvum is the major Cryptosporidium involved in NCD and it is a 
potential zoonotic agent65,91. This protozoon replicates in the enterocytes causing the loss of micro-
villus structure92. The damage to the intestinal epithelium causes prolonged malabsorption and 
poor growth93. 
Infection occurs when oocysts are ingested from the environment. Once in the host, the organism 





Figure 5. Schematic representation of the Cryptosporidium parvum life cycle. After excysting from oocysts in the lumen of the 
intestine (a), sporozoites (b) penetrate host cells and develop into trophozoites (c) within parasitophorous vacuoles confined to 
the microvillous region of the mucosal epithelium. Trophozoites undergo asexual division (merogony) (d and e) to form 
merozoites. After being released from type I meronts, the invasive merozoites enter adjacent host cells to form additional type I 
meronts or to form type II meronts (f). Type II meronts do not perform asexual reproduction, instead they enter host cells to form 
the sexual stages, microgamonts (g) and macrogamonts (h). Most of the zygotes (i) formed after the fertilization of the 
microgamont by the microgametes (released from the microgamont) develop into environmentally resistant, thick-walled oocysts 
(j) that undergo sporogony to form sporulated oocysts (k) containing four sporozoites. Sporulated oocysts released in the feces are 
environmentally resistant life cycle forms that transmit the infection from one host to another. A smaller percentage of zygotes 
(approximately 20%) do not form a thick, two-layered oocyst wall; they only have single membrane surrounding the four 
sporozoites. These thin-walled oocysts (l) represent auto-infective life cycle forms that can maintain the parasite in the host 
without repeated oral exposure to the thick-walled oocysts present in the environment. 
 
 
C. parvum oocyst shedding occurs as early as 3 days of age, reaching a peak at 2 weeks of age, and 
can continue to occur in adult cattle. However, diarrhea caused by C. parvum rarely occurs after 3 
months of age65. After infection, clinical signs peak at 3 to 5 days and last 4 to 17 days94. Some 
studies have shown that up to 100% of dairy calves become infected with C. parvum,95,96 therefore 
representing the major source of environmental contamination; a calf can shed up to 107 oocysts 
per gram of feces97. Shedding in beef calves is not as frequent and occurs in less than 5% of calves98.  
Calves appear to be resistant to subsequent infection after the initial episode of C. parvum diarrhea. 
Severity of diarrhea and incidence of clinical signs in calves shedding oocysts can be variable within 
and between farms, leading some to question the true importance of C. parvum as a primary 
pathogen;99 however, it has been repeatedly isolated from clinical cases associated with other 
known pathogens. Infection with C. parvum has been shown to induce severe villous atrophy (Fig. 
2) in calves and other production animals94. This atrophy is caused by the loss of villous enterocytes 
and the subsequent retraction of the villous to maintain a continuous epithelial barrier. Crypt 
hyperplasia also occurs in an effort to replace the lost epithelial cells, however in severe infections, 
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disruption of the epithelial barrier can occur despite these efforts94. Furthermore, taking into 
account the loss of epithelial surface area, an increase in epithelial permeability has been found in 
both cell cultures and animal models infected with C. parvum100. In spite of this well recognized 
consequence of C. parvum infections, the precise mechanism of cell loss remains elusive. It is still 
not understood whether the cell loss is an effect of the pathogen or is part of the host response in 
an effort to resolve the infection. 
 
Other pathogens of NCD 
There are more than 2000 serotypes of Salmonella spp. negative, facultative anaerobic bacteria, 
asporigenous, which belong to the Enterobacteriaceae family. The predominant strains isolated in 
bovines are S. dublin and S. tiphymurium. The latter represents a potential zoonotic agent. 
Salmonella spp. may cause gastrointestinal disorders, bronchopneumonia, septicaemia, meningitis 
and abortion101. Diarrhea caused by Salmonella spp. is profuse, watery, very often haemorrhagic, 
with the presence of necrotic intestinal mucosa and fibrin. The infection has fecal-oral transmission. 
The microorganism manages to persist for a long time in moist soil, bedding or feed101. 
Clostridium perfringens is a Gram-positive, anaerobic, spore-forming bacterium. It is able to cause 
a wide range of diseases in vertebrates and it can be differentiated into 5 categories ((A, B, C, D 
and E) according to the type of toxin it produces. Its role as a pathogen of NCD is secondary, but 
when involved it causes multifocal necrotizing enteritis, characterized by profuse, liquid and 
haemorrhagic diarrhea102. 
Norovirus is a single-stranded RNA virus belonging to the Caliciviridae family, with a very low 
zoonotic potential103. Norovirus was found in the faeces of calves affected by NCD with a 
prevalence that ranged from 1.6% to 49%, values that suggest its own possible significant 
contribution to the pathogenesis of the pathology104. 
Norovirus is a single-stranded RNA virus that is a member of the of the Caliciviridae family. It was 
initially associated with some cases of neonatal diarrhea in the United Kingdom in 1978105 (and 
then isolated in other countries as well, including Italy106. Norovirus has been isolated in healthy 
calves and calves with NCD, with a higher prevalence in sick animals that can reach 7-21 %107. 
Other viruses have been detected in healthy calves affected by NCD, including Torovirus, 





Clinical presentation of NCD 
The most important clinical sign of NCD is the alteration of the consistency and volume of the 
faeces. Fecal water loss may increase 28-fold, fecal volume 22-fold and fecal water content increases 
from 73% to 94%. NCD also causes a considerable amount of systemic effects that can be classified 
into two macro-categories; the first represented by the loss of extracellular fluids and electrolytes, 
the second by malabsorption of nutrients108. This results in variable degrees of dehydration, acid-
base and electrolyte imbalance and hypoglycaemia which are frequently found in association with 
fecal alteration during NCD.  
The first response to the loss of extracellular fluid and electrolytes is the reduction of fluid loss 
from the kidney along with severe losses of sodium (Na) and chlorine (Cl) ions and considerable 
losses of bicarbonate ions (HCO3)89. Contraction of extracellular fluid volume gives rise to the 
clinical signs of sunken eyes and ‘tenting’ of skin folds; it leads to a fall in arterial blood pressure, 
which stimulates peripheral vasoconstriction. Peripheral vasoconstriction leads to poor tissue 
perfusion with a localized ischemia. The temperature of peripheral tissues falls approaching 
ambient temperature prior to death; the extremities, ears and mouth, feel cold. Reduction of plasma 
volume leads to poor tissue perfusion, hypotension, lower metabolic activity, decrease in 
glomerular filtration and consequently, hyperkalemia and pre-renal azotemia109. Metabolic acidosis 
is a frequent complication of NCD. Historically, metabolic acidosis and electrolyte imbalance in 
NCD were thought to be mainly associated with bicarbonate and electrolyte fecal loss. In the past, 
the causes of this condition were considered to be the dehydration and reduced renal perfusion 
which in turn lead to reduced excretion of hydrogen ions and accumulation of L-lactate and other 
unidentified organic anions110,111. Recently, scientific works have reported that D-lactate is a major 
component of high anion gap acidosis in NCD112. High D-lactate concentrations have been found 
in the feces of diarrheic calves113. This finding suggested that the gut was the source of D-lactate, 
produced almost exclusively by microbes. The pathogenesis of D-lactic acidosis in diarrheic calves 
is hypothesized to involve a decrease in the absorption of substrates with its subsequent 
fermentation in the gastrointestinal tract114. The acid pH in the gut allows acid-resistant Gram-
positive bacteria, particularly Lactobacillus spp., to proliferate and produce high concentrations of 
D- and L-lactate115. Subsequently D-lactate is absorbed in the circulatory system. Here, D-lactate 
accumulates because it is metabolized by mammals at approximately one fifth the rate of L-
lactate116. Recent works reported that most clinical signs (alterations in posture, behavior and 
suckling reflex) of metabolic acidosis were attributed to an increase in the levels of D-lactate in the 
blood117. D-lactate has a direct toxic effect on the brain. Abeysekara et al.118 suggested that D-
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lactate interferes with the energy metabolism in the CNS by competitively blocking L-lactate entry 
into neurons, where L -lactate has an important role as a source of energy. Gentile et al.119 induced 
hyperchloremic metabolic acidosis with a mean base deficit of up to 22.4 mmol/L with an IV 
infusion of 4000 mL of a solution containing 400 mmol of hydrochloric acid in 0.9% NaCl over a 
period of 80 min in healthy calves. Despite the relatively severe acid-base imbalance during the 
entire observation period, no calves showed any clinical signs or decreased appetite. Abeysekara et 
al.118 induced acidosis with an infusion of either iso-molar DL-lactic acid, L-lactic acid, or HCl, 
respectively, during a period of 6 h. Only DL-lactic acidosis was associated with severe disturbances 
in neurological functions. A further study of this subset of diarrheic calves with moderate to severe 
acidosis indicated that D-lactate, rather than metabolic acidosis per se, was associated with 
impaired posture, behavior, and especially impairment of the palpebral reflex, whereas the sucking 
reflex appeared to be influenced by dehydration and metabolic acidosis117. In an attempt to prove 
this hypothesis, D-lactatemia without acidosis was induced in a blinded study involving five 
clinically healthy calves with an injection of 100 mL of a 25% Na-D-lactate solution, while five 
control calves were given the same volume of 0.9% sodium chloride. The administration of D-
lactate resulted in profound changes in posture and behavior, while saline did not produce these 
changes120. However, the injection of 100 mL of a 25% Na-L-lactate solution followed by infusion 
of 300 mL of the same solution over a period of 35 min did not trigger any clinical signs, so 
hypernatremia and hyperosmolarity could be ruled out as reasons for the clinical signs in the study 
of calves with experimentally induced D-lactatemia119. These studies led to the conclusion that 
metabolic acidosis without appreciable increase in D-lactate concentrations only had a minor 
influence on posture and behavior. However, it is still possible to determine bicarbonate 
requirements in calves with naturally acquired diarrhea because of the significant correlation that 
exists between D-lactate concentrations and base excess values112. Trefz et al.121 showed that 
clinical parameters such as posture, behavior, and palpebral reflex were either closely correlated to 
base excess (BE) or D-lactate concentrations. These results demonstrated that the degree of 
metabolic acidosis in diarrheic calves can be predicted based on clinical findings. Clinical signs 
provide a useful tool to determine bicarbonate requirements, but a revision is necessary for calves 
who are able to stand with marked metabolic acidosis121. In diarrheic calves, DL-hyperlactatemia 
induces an increase in the anion gap (AG)122. AG is widely employed in diagnosing metabolic 
acidosis in cattle and is used to differentiate metabolic acidosis caused by bicarbonate loss from 
the one caused by an accumulation of organic acids122-124. Calculation of AG is based on the 
principle of electroneutrality and is calculated as the difference between routinely measured cations 
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and routinely measured anions123. Values in normal animals have a pronounced variability and 
range between 7.1 to 22.6 mmol/L115,124,125. Normal positive value of AG representing the charge 
on serum proteins, phosphate, and strong anions, which are not routinely measured. Normally, 
approximately two thirds of the AG originates from the net negative charge of serum proteins123. 
Increases in AG generally are indicative of a gain of organic anions such as ketoacids, DL-lactate 
or uremic anions122-124. Decreases in AG generally are indicative of laboratory error, 
hypoalbuminemia, and reduction in sTP concentrations in adult cattle123,126. Hyperkalemia has 
been described as another clinically important electrolyte disturbance127 that can result in skeletal 
muscle weakness and potentially life-threatening cardiac arrhythmias with concomitant progressive 
atrial standstill and prolonged ventricular depolarization128. Hyperkalemia has traditionally been 
attributed to concomitant acidemia with intracellular buffering of hydrogen ions in exchange for 
potassium ions and impairment of the Na/K-ATPase129. Recently Trefz et al.109 have reported that 
dehydration is an important contributor to the pathogenesis of hyperkalemia and acidemia in 
neonatal calves with diarrhea. Potassium filtered by the glomeruli is almost entirely reabsorbed by 
the proximal tubule cells, so that potassium excretion strictly depends on secretion by the distal 
tubules in exchange for Na and Cl ions130. Experimental studies in rats have shown that this process 
is strongly influenced by urine flow and distal tubular delivery of Na131. Therefore, an increased 
proximal tubular reabsorption of sodium and water in response to hypovolemia, and a decrease in 
glomerular filtration rate due to hypovolemia, result in a reduced distal tubular potassium secretion 
and thereby an increased risk of hyperkalemia in calves with pre-renal azotemia109. Hypoglycemia 
frequently occurs in calves with severe diarrhea, especially young calves close to death. Anorexia, 
decreased absorption of nutrients, minimal glycogen reserves, inhibited gluconeogenesis, increased 
glycolysis due to reduced tissue perfusion and anoxia may contribute to hypoglycemia. Signs of 
hypoglycemia are weakness, lethargy, convulsions and coma. 
 
Therapy of NCD 
The first step in the treatment of NCD is to correct dehydration and the imbalance of acid-base 
and electrolytes. To achieve this goal, it is possible use two main methods: oral rehydration solution 
or intravenous fluid therapy. Adjunct treatment of NCD should be routinely undertaken in all 
calves with systemic signs of illness; manifested as fever, inappetence, or lethargy. Ancillary 
treatments with documented efficacy in NCD include parenteral administration of non-steroidal 
anti-inflammatory agents such as meloxicam and flunixin meglumine, as well as continued feeding 
of cow's milk. Halofuginone and azithromycin are effective in calves with diarrhea caused by C. 
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parvum, and their administration should be considered in calves documented or suspected to have 
cryptosporidiosis132. The role of antibiotics is controversial in NCD. Parenteral administration of 
broad-spectrum-lactam antimicrobials or potentiated sulphonamides is recommended for treating 
calves with diarrhea and systemic illness, although in cases of non-complicated diarrhea (normal 
appetite, no fever), antimicrobial use should be omitted81.  
Oral rehydrating solutions (ORI) can be an effective mean of restoring the liquids and electrolytes 
lost as a result of diarrhea. SROs contain first of all water, which is essential to solve dehydration, 
to which part alkalizing agents are added to combat acidemia, including sodium bicarbonate, 
propionate or sodium citrate, on the other hand, the glucose that fights hypoglycemia, 
hyperpotassemia and to balance negative energy133. SRO can be an effective method of controlling 
dehydration, especially when the calf maintains an adequate suckling reflex. The administration 1-
2 L of SRO, 2-3 times per day, in addition to the normal milk ration, should be given at the first 
symptoms of NCD, to prevent aggravation of dehydration, and it should be continued until 
symptoms disappear133. 
Based on the amount of substances contained, there are iso-osmotic SROs, those most widely used 
and that can be administered to calves by spontaneous sucking as described previously, and 
hyperosmotic ones, which produce greater blood electrolytes. The latter can also be used to 
increase blood sugar levels, however, could also be detrimental to the hydration of the animal 
because they could induce further water loss from the crevice, and should therefore only be used 
if dehydration has been resolved beforehand133. 
Infusional treatment is defined as the administration of a crystalloid or colloidal solution 
intravenously. The most used venous accesses with regard to the bovine species are the jugular vein 
or the auricular veins 134. Usually iso-osmotic crystalloid solutions are used in large volumes at a rate 
between 30mL/kg/h up to even 80mL/kg/h, in order to correct dehydration and volemia. In order 
to determine the volume of solution needed, it is necessary to sum up the losses of liquids that have 
already occurred, which are estimated on the basis of dehydration as described above, to the 
current ones, that correspond to the quantity of fluids required daily to maintain organic functions, 






To correct acidemia, the following substances are used alkalizing, primarily NaHCO3, as it 
represents one of the most lost substances in the case of diarrhea. To determine the quantity of 
bicarbonate to be administered to carry forward the blood pH under normal conditions the 
following formula may be used: 
 
B.E. (mmol/L) x p.v. (kg) x 0,6 x 84/1000= g of NaHCO3 
 
where p.v. stands for the live weight of the animal, 0,6 is the coefficient which represents the 
amount of extracellular fluids in the calf, and 84 is the molecular weight of sodium bicarbonate 136. 
To prevent hypoglycemia and resolve the hyperkalemia caused by the NCD, it is important to 
administer glucose together with fluid therapy (5 g/kg die), at least as long as the calf is not able to 
feed itself137. 
The role of antibiotics is controversial in NCD. Parenteral administration of broad-spectrum-
lactam antimicrobials or potentiated sulphonamides is recommended only for NCD calves with 
systemic illness. Despite that, in Italy, practitioners systematically use antibiotics in cases of 
NCD138. In addition, antimicrobial treatments in other infections caused by E. coli (eg. Mastitis 
Acuta Gravis), have been reported as detrimental139. In fact, lipopolysaccharides (LPS), a 
component of the cell wall of gram-negative bacteria, are considered the primary virulence factor 
of coliform bacteria80, responsible for most pathophysiological reactions in E. coli sustained 
diseases such as Mastitis Acuta Gravis140. LPSs are released from the bacteria following cell death 
caused by antibiotics140,141. Clinical signs in acute coliform mastitis are induced by LPSs as the 
consequence of the release of inflammatory mediators140-142. Also, in NCD, there is a massive 
release of LPSs that can result in a worsening of the clinical conditions81. Furthermore, the 
European guidelines suggests developing alternative, preferably preventive tools to control 
infections.  
The use of non-steroidal anti-inflammatory drugs (NSAIDs), such as meloxicam or flunixin 
meglumine, is strongly recommended and also brings an increase in appetite and an improvement 
in general conditions, especially during the course E. coli infections132. 
The use of glucocorticoids or motility modifiers, widely used in the past, is not recommended 
because these active ingredients may hide symptoms and affect the evaluation of the clinical efficacy 




Risk factor for mortality in calves affected by NCD 
Previous studies have reported the use of some clinical data, hematological and serum biochemical 
constituents for predicting the survival of diarrheic calves.	 
Fayet and Overwater143, have shown that blood urea concentration had the best prognostic value 
and concluded that, by measuring two other parameters (the hematocrit and blood chloride 
concentration), they were able to classify the calves into two distinct groups (dead or survivors) 
with an 80% accuracy. Klee et al.144 stated that treatment in diarrheic calves was less successful 
when the hematocrit was over 50% and the blood urea nitrogen concentration (BUN) was over 
28.56 mmol/L. Seifi et al.62 showed that concentration of K was significantly higher in diarrheic 
calves that died compared to those who survived. Calves with BUN levels above 13.07 mmol/L and 
K concentrations above 5.63 mEq/L were 5.6 and 4 times more likely to die, respectively62. Recent 
evidence suggests that calves with elevated D-lactate blood concentrations do not need additional 
specific therapy and D-lactatemia has no impact on the prognosis of calves with metabolic 
acidosis112,136. Bacteremia is an important cause of morbidity and mortality in large animal neonates 
and neonatal diarrhea predisposes calves to septicaemia53. Lofstedt and his colleagues53 presented 
two models (a laboratory and a clinical model) for predicting septicemia based on all possible 
predictors studied. Fecteau et al.145 described a clinical score intended to be used on the farm and 
a more complete scoring system intended to be used in patients on which ancillary tests were 
performed. The study by Fecteau et al.145 indicated that the model used was a suitable tool for 
predicting bacteremia in ill calves in a clinical setting. Total clinical scores (fecal score, hydration 
score, attitude score, umbilical score and scleral vessel score) were strongly associated with 
bacteremia145. Risk of bacteremia increased with age, indicating that calves 1-week old or older 
were more at risk than younger calves. Lofstedt et al.53 showed that moderate (176–500 mmol/L) 
and marked (>500 mmol/L) increases in serum creatinine concentration, moderate and marked 
toxic changes in neutrophils, and ITPI (IgG concentration ≤800 mg/dL and total serum protein ≤50 g/L) were associated with an increased risk of septicemia. In this study moderate and marked 
increases in serum creatinine concentration increased the risk of a calf being septicemic by 2-and 
8-fold, respectively. The clinical model used by Lofstedt et al.53 showed that a significantly larger 
proportion of septicemic calves was <5 days of age. Moreover, recumbency and absence of a 
suckling reflex were positively associated with an increased risk of septicemia53. Koch and Kaske146, 
evaluated the clinical efficacy of IV administered hypertonic saline solution and hypertonic 
bicarbonate solution in the treatment of inappetent diarrheic calves. The results of this study have 
shown that treatment failed in 6 calves subjected to hypertonic saline solution and in 1 calf 
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subjected to hypertonic bicarbonate solution. All treatment’s failures had more severe metabolic 
acidosis compared with successfully treated calves before treatment and no further differences 
between successfully treated calves and treatment failures were found (sTP, clinical data, glucose, 
potassium etc.).  
 
Long term effect of NCD 
Numerous studies have been carried out to investigate the effects of long-term diseases of the 
growing period of the calf. Britney et al.147 followed a cohort of calves (460) from two holdings for 
a total period of time of eight years. The results did not show any statistically significant difference 
among the milk production of adult animals who had no calf disease than those who had developed 
respiratory diseases or gastro-enteric disease 147. Another study conducted out of 25 farms in the 
state of New York, for a period of 10 years, took into account all pathologies in the period and 
showed that diarrhea and diseases are not only a problem, but also a problem. respiratory in the 
first 90 days have no long-term effects on milk production148. Also, Heinrichs & Heinrichs149 did 
not show any statistical differences of milk production among the subjects who had experienced 
episodes of diarrhea in the first 4 months of life and healthy animals149. Waltner-Toews et al.150, in 
a study carried out on 104 holdings in Ontario, found that the calves that presented an episode of 
diarrhea in the first 90 days of life, had a 2.86 times higher probability of giving birth over 900 days. 
Rossini151 investigated the reproductive effects of NCD and bronchopneumonia enzootics (BRD) 
on first lactation on a sample of 2556 cattle. This study showed that the production of milk 
normalised to 305 days and the quantity of fat was not affected by diseases of the growing season, 
while the animals that had manifested episodes of BRD were found to have a statistically significant 
protein production of 0,05 kg/day. In addition, it was found that the animals with BRD or NCD 
were older at later birth of two weeks. Again, the animals that survived the episodes of BRD or 
NCD have been shown to have a survival probability 5% lower than healthy animals during the 
first lactation. Aghakeshmiri et al.152 highlighted a statistically significant difference of 10 days 
between age at the birth of animals that had experienced episodes of NCD compared to healthy 
subjects. Svensson & Hulgen153, as opposed to previous studies, have shown, on a sample of 2000 
animals, that the subjects that had had episodes of diarrhea produced 344 kg less of milk, during 
the first lactation, than the other subjects. 
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Microbiota of calves 
The complex living entities in the gut defined as microbial communities have increased interest in 
recent years. The evolution of advanced molecular methods has prompted studies dedicated to 
understanding the microbiota composition. These studies shown that animals host a wide diversity 
of microbial communities. These microbial communities have evolved with animals as a result of 
complex and mutualistic interactions, and they play crucial roles in their biology and health 
status154,155. 
The term microbiota was first defined by Lederberg and McCray156 who emphasized the 
importance of microorganisms inhabiting the human body in health and disease. This microbial 
census is established using molecular methods relying predominantly on the analysis of 16S rRNA 
genes, 18S rRNA genes, or other marker genes and genomic regions, amplified and sequenced from 
given biological samples. Taxonomic assignments are performed using a variety of tools that assign 
each sequence to a microbial taxon (bacteria, archaea, or lower eukaryotes) at different taxonomic 
levels from phylum to species. 
The most studied microbiota is the gut one, where the microbial community is highly evolved, 
complex and closely interconnected with the host157-159. It is clear that the intestinal microbiota 
exerts influence both locally and extra-intestinally, and alterations of the microbiota can be 
associated with a wide range of infectious, inflammatory, metabolic, and other diseases in many 
species157,158.  
Recently, in calves, as in other species, an increasing number of studies have been investigating the 
composition of the microbiota in healthy animals and its modifications have been studied and 
correlated with productive performance, diseases, and antibiotic treatments. 
The development of intestinal microbiota in neonatal calves is a dynamic and complex process 
influenced by external and internal factors that affect intestinal microbial succession160. External 
factors include microbial load in the environment, delivery mode161, type of colostrum162, type of 
feeding (raw milk versus pasteurized milk versus milk replacer),163 housing164, and administration 
of probiotics, prebiotics, or antibiotics165-167. Individual factors that can influence gut microbiota 
include nutritional state, functional immaturity of the immune system, intestinal pH, peristalsis, 
bile acids, bacterial mucosal receptors, and microbial interactions168. 
The fecal bacterial composition of dairy calves undergoes dynamic changes during the first 12 
weeks of life169. These changes include the appearance of new species such as Ruminococcus 
flavefaciensand, Fibrobacterspecies and the disappearance of Bifidobacterium, Enterobacteriaceae, 
Streptococcus, and Lactobacillusspecies169, suggesting that both diet and gut development may drive 
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changes in the bacterial composition during early life. A previous report showed that, at the phylum 
level, the gut microbiota in healthy calves were dominated by Firmicutes (64–82%), followed by 
Bacteroidetes (8–24%) and Actinobacteria (1–12%) during the neonatal period170. 
A recent study reported a link between the prevalence of Fecalibacterium during the first week of 
life and body weight gain as well as diarrhea incidences in 4-week-old calves170. This suggests a 
potential role for gut bacteria in both animal health and production. Evidence is also emerging that 
the initial acquisition of, and continuous exposure to, microbes results in a host-specific gut 
microbiome, which plays a vital role in the maturation of the mucosal immune system171,172. Hence, 
knowledge regarding the pioneer bacterial community of calves provides an opportunity to 
understand how perturbations in microbial composition and diversifications may alter health and 
production in cattle173. 
Disruption of this ecosystem, otherwise known as “dysbiosis,” can trigger gastrointestinal 
disorders174. To date, the molecular basis of dysbiosis and the key bacterial groups involved remain 
poorly defined. It is clear however that if the gut microbiota is disrupted (eg, antibiotic treatment, 
gut inflammation) the risk of disease can increase substantially175-177 and re-establishment of the 
normal microbiota can result in recovery from disease178. Despite current attention and research 
on the gut microbiota, few population-based studies have been conducted in cattle to better 
understand how the microbiota and its functional potential are impacted during neonatal diarrhea. 
Calf diarrhea may be associated with altered microbial diversity and decreased abundance of 
butyrate-producing microorganisms during the first weeks of life170. In the early stages of life in the 
calves, the incidence of diarrhea was associated with a decrease in bacterial diversity in the gut170.  
More studies found that Proteobacteria was associated with gut dysbiosis and inflammation 179. In 
particular, one study showed that Proteobacteria was abundant in rotavirus diarrhea samples. In 
the same study, was found that, at the genus level, in rotavirus-infected calves, there was significant 
increase of the genera Escherichia, Clostridium, and Streptococcus. However, Subdoligranulum, 
Blautia, Bacteroides, and Coprococcus were decreased. Notably, Lactobacillus was significantly 
decreased in the rotavirus diarrhea group180. 
Antimicrobial administration has been shown to have an impact on the intestinal microbiota in 
various species, including humans, pigs, horses, and laboratory animals,181-184 but there has been 
limited study in cattle, despite the commonness of antimicrobial exposure in commercial beef and 
dairy cattle185. Penicillin administration was shown to significantly alter the microbiota in calves <6 
months of age;186 however, the methods that were used (automated ribosomal intergenic spacer 
analysis and terminal restriction fragment length polymorphism analysis) could not provide insight 
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into the nature of those changes. A study by next-generation sequencing, reported decreased 
bacterial richness in calves with pneumonia that were treated with antibiotics, as well as calves with 
diarrhea that were not treated170. Another next-generation sequencing study identified changes in 
some taxa in dairy calves which were fed milk with antibiotic residues compared to untreated 
controls; however, these were relatively limited in number and restricted to the genus level165. 
In conclusion, the study of the microbiota allows to increase the knowledge on intestinal changes 
due to management, diseases and antibiotic treatments. The increase of information about the 
microbiota, may in the future, help the prevention of gastrointestinal diseases through the 
modification of the intestinal microbial community, thus implementing local immunity, limiting 
the inflammatory states of the intestine and consequently limit the incidence of gastrointestinal 
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Aim of the study 
 
The aim of this project is to investigate if there could be a correlation between failure of passive 
immunity transfer (ITPI) and neonatal calf diarrhea (NCD). To achieve this goal, four specific aim 
was investigate.  
The first aim is to compare two indirect methods: serum total protein (sTP) and gamma-glutamyl 
transferase (GGT) activity, in calves affected by NCD in order to discriminate calves with or 
without adequate passive immunity transfer, considering the dehydration status and age of the 
calves. Evaluating the indirect methods used to identify ITPI in calves affected by NCD is 
important for the decision-making process as well as the treatment and prognosis of NCD.  
The second aim is to review clinical and laboratory findings in diarrheic calves referred to our clinic 
to identify major risk factors associated with NCD case fatality risks in calves treated with a 
standard therapeutic protocol.  
The third aim is to evaluate the efficiency of antibiotics during NCD and their influence on the gut 
microbiota, considering the immunity status of the calf. Mortality rate, growth rate in survivors, 
and duration of diarrhea were used to evaluate the success of therapy. Testing the real efficiency of 
the antimicrobial treatment in NCD is important to unify the therapy protocol of NCD and to 
reduce unnecessary antibiotic treatments. Despite current attention and research on the gut 
microbiota, few population-based studies have been conducted in cattle to better understand how 
the microbiota is impacted during NCD.  
The last aim is the evaluation of the long-term effects of NCD during the first lactation. To achieve 
that, the age of the first calving, the length of the first lactation (days in milk), 305-d equivalent 
milk yield, milk fat and protein content in the first lactation of heifers were compared between 
heifers that survived a mild to severe episode of NCD and treated at a veterinary teaching hospital 






1. Comparison between Gamma-Glutamyl-Transferase (GGT) activity and serum Total 
Protein (sTP) as a method to detect inadequate transfer of passive immunity in calves affected by 
neonatal calf diarrhea 
 
2. Risk factors associated with case fatality in 225 diarrheic calves: A retrospective study 
 
3. Evaluation of antibiotic treatment in neonatal calf diarrhea and its influence on fecal 
microbiota 
 
4. Frequency and severity of calf diarrhea cases treated with a standard veterinary hospital 
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This study aims to compare serum total protein (sTP) and gamma-glutamyl-transferase (GGT) 
activity in calves affected by NCD to discriminate calves with or without adequate transfer of 
passive immunity (ITPI) 
43 Holstein Friesian calves admitted to the Clinic for Ruminant and Swine (CTS)-Veterinary 
Teaching Hospital of the University of Milan for neonatal calf diarrhea (NCD) were enrolled from 
May 2018 to May 2019. For each calf, age, dehydration degree, hematocrit, sTP, GGT activity and 
immunoglobulin G (IgG) were measured and recorded. 
The results underline the influence of the dehydration degree (p 0.02) on sTP concentration and 
the association between age and GGT activity concentration (p 0.01). The ROC curve analysis, 
considering the influence of dehydration degree and age of calves, showed different cut-off points 
for sTP in normohydrated calves (52 g/L) and dehydrated animals (56 g/L), with high sensibility 
(1 and 0.8 respectively), but low sensitivity (0.6 and 0.58 respectively). The cut-off points of GGT 
activity, based on the age of the calves, resulted from 295 UI/L in calves with 5 days or more and 
100,5 UI/L in calves oldest than 5 days, with high sensitivity (1 and 0.85 respectively) and good 
sensibility (0.75 and 0.77 respectively). GGT is an interesting test to use in the case of NCD because 
the variability of results appears to be associated only with the age of the animals and not with the 
effects of diarrhea. Therefore, the results suggest that the GGT activity is a more accurate test for 
detecting ITPI in calves affected by NCD compared to the sTP.  
 
Introduction 
Neonatal Calf Diarrhea (NCD) is a multifactorial disease that affects calves during the first month 
of life which results from the interaction amongst the immunity of calves, their environment, and 
pathogens1. 
Calves at birth have a naïve immunity system and their immune protection is almost exclusively 
ensured by the maternal immunity transferred by the ingestion of colostrum in the first hours of 
life2. Inadequate transfer of passive immunity (ITPI) has been related to increased morbidity and 
mortality in calves3. Furthermore, calves with ITPI have a 24 times greater risk of developing NCD4 
and are more likely to be bacteremic5,6.In order to consider the transfer of passive immunity to be 
adequate, it has been shown that the immunoglobulin G (IgG) concentration must be greater or 
equal to 10 g/L at 1-7 days7-9. Several methods have been used to measure the IgG in calves, 
including both direct and indirect methods. The direct methods are reliable when diagnosing ITPI, 
but they require a specialized laboratory, which is expensive and the results are not immediately 
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available10. For these reasons the direct methods are not applicable in field conditions10. Amongst 
the indirect methods, optical or digital refractometry are the most used techniques to estimate IgG 
in the field. The most used cut-off is 52 g/L sTP with a sensitivity and specificity of 76.1% and 
89.3%, respectively11. In calves younger than 21 days, unable to stand without assistance and 
lacking the suckle reflex, the cut-off proposed was 55 g/L for sTP12. However, this method is 
strongly influenced by dehydration which induces an increase in prothydemia13.  
Another well-documented indirect method to estimate IgG and the transfer of passive immunity is 
the determination of gamma glutamyl-transferase (GGT) activity14-16. This method requires 
laboratory analysis but is cheaper and faster compared to the direct method. However, GGT 
activity decreases significantly after birth, as opposed to concentrations of IgG and sTP, which are 
relatively constant up to 7 days of age17. The cut-offs proposed for GGT activity are age-related. 
In fact, in healthy calves < 3 days it is recommended to use 200 IU/L as a cut-off, while in healthy 
calves aged between 5 and 7 days a cut-off of 75 IU/L is suggested16. In calves aged less than 21 
days, unable to stand without assistance and lacking a suckle reflex the cut-off proposed is 50 
IU/L12. Furthermore, when sTP in sick calves is tested, dehydration could cause a bias in the 
concentration, creating the potential for misclassification by increasing the proportion of false-
negative tests for ITPI12. For the GGT activity, no influence of dehydration is reported, but the 
influence of age is well documented15,16,18,19. 
The accuracy of sTP and GGT for the detection of ITPI in calves affected by NCD is not available. 
The aim of this study is to compare sTP and GGT activity in calves affected by NCD in order to 
discriminate calves with or without adequate passive immunity transfer, considering the 
dehydration status and age of the calves. 
 
Materials and methods  
Study subject and sample collection 
The present study was approved by the Ministry of Health (approval number 14/2018). 
The study population consisted of client-owned dairy calves admitted to the Clinic for Ruminant 
and Swine (CTS)-Veterinary Teaching Hospital of the University of Milan from May 2018 to May 
2019 with a clinical diagnosis of NCD on initial examination. At admission, complete physical 
examinations followed a standardized protocol and were carried out by one of the main authors 
belonging to the CRS. Clinical diagnosis of NCD was based on the presence of watery feces in 
calves aged between 1-28 days of life. The presence of other concurrent diseases at admission was 
used as an exclusion criterion. Dehydration score was estimated according to the scale proposed 
 45 
by Boccardo et al.20 as reported in Table 1. Because of regional preferences, most of the calves 
admitted to CRSM were Holstein Friesian (>90%), only these calves were admitted to the study. 
The management of all calves undergoing the study was within standard protocols of the CRS for 
the treatment of NCD20. Calves were referred by veterinary field practitioners or by owners who 
are knowledgeable about our therapy protocols. Before treatment was initiated, two blood sample 
were performed. The first blood sample was collected in a 9-mL tube without anticoagulant from 
the jugular vein and used to determine sTP and GGT. Samples were allowed to clot and then 
centrifuged at 20 °C for 10 min at 900 g. The serum was harvested and frozen for future analysis. 
None of the samples were grossly haemolyzed. 
The second blood sample for venous blood-gas analysis was also anaerobically collected from the 
jugular vein into a disposable heparinized 2.5 mL syringe. Acid-base imbalance and hematocrit 
were immediately determined using a blood gas analyzer (Epoc blood analysis, Epocal Inc., 
Ottawa, Canada). After admission, calves were housed in individual pens bedded with straw. 
Freshwater, hay and calf starter were offered ad libitum. Calves were fed 2 L of milk replacer 
(Solvor MG + Instant, Bonilait) three times daily. Uniform treatment procedures were ensured by 
daily patient rounds performed by at least one experienced clinician. Calves were monitored twice 
daily with complete clinical examinations.  
 
IgG, sTP and GGT determination 
Serum IgG was determined by radial immunodiffusion (RID) using bovine IgG commercial kit 
(Bovine IgG Test Kit Radial Immunodiffusion Test Kit, Triple J Farms, Washington, USA) 
according to the manufacturer’s instructions. The sTP concentration was measured by handle 
refractometer by the same operator (GS). Gamma-glutamyl transferase (GGT) activity was 
determined using an automated spectrophotometer (BT 3500, Biotecnica instruments, Roma, Italy) 
and reagents provided by Futurlab srl (Limena, Padova). The method used is enzymatic-
colorimetric-kinetic, based on the formation of a coloured compounds, the 5-amino-2-
nitrobenzoate, which can be measured at a wavelength of 405 nm. The increase in absorbance at 
this wavelength is directly related to the activity of GGT in the sample. 
 
Data analysis 
Descriptive statistics were performed and continuous variables were expressed as the mean ± SD, 
while categorical variables were expressed as frequencies and percentages. Calves were classified 
as ITPI when the IgG concentration, measured with RID, was less than 10 g/L.  
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Receiver operating characteristic (ROC) curve analysis was performed to identify the optimal cut-
off point in the sample tested. The optimal cut-off point was chosen using the Youden index, where 
sensitivity and specificity are maximized, and equal weight is given to false-positive and false-
negative results. The cut-off points determined by the ROC curves, and the cut-off points present 
in the literature for ill calves (55 g/L for sTP; 50 UI/L for GGT activity12), were used to calculate 
sensitivity (Se), specificity (Sp), positive predictive value (PPV), negative predicted value (NPV) 
and accuracy of sTP and GGT activity using IgG as a gold standard in claves affect by NCD. 
Furthermore, the area under the curve (AUC) and its 95% confidence intervals (CI) were 
calculated and used as an indicator of the test’s ability to discriminate calves with and without ITPI. 
Interpretation of AUC was based on 1.0 perfect test, 0.99–0.90 excellent test, 0.89–0.80 good test, 
0.79–0.70 fair test, 0.69–0.51 poor test, and 0.50 fail21.  
The effect of hematocrit, dehydration degree and age of the calves on the concentration of sTP, 
GGT activity and the concentration of IgG was investigated using two separate multivariable linear 
regression models. Hematocrit, dehydration degree, age of calves and results of the test were the 
only predictor. Interactions were considered significant when the p-value was ≤ 0,05.  
In case of interaction of predictors with sTP or GGT concentrations, calves were classified as 
reported in table 2 and separate analysis of ROC curves, Se, Sp, PPV, NPV, and accuracy were 
carried out.  
All statistical analyses were computed using SPSS 25.0 for Mac (IBM, Armonk, USA). 
 
Results 
A	total	of 69 calves with NCD were	evaluated during the study period. Of these, 55 calves were 
Holstein Friesian breed and 43 had no clinical signs of other concomitant diseases. In accordance 
with the selection criteria, 33 female (76.7%) and 10 male calves (23.3%) were included in this 
study. The average age was 7 ± 4 days. Ten calves (23.3%) had a dehydration score of 0 
(normohydrated calves), 13 calves (30.2%) had score 1, 15 (34.9%) had score 2 and 5 calves 
(11.6%) had score 3. The average hematocrit was 31.42 ± 7,5%. 
Serum samples of these diarrheic calves were tested for concentration of IgG, sTP and GGT 
activity. The average of IgG, sTP and GGT activity were 11.4 ± 5.4 g/L, 57.6 ± 11.8 g/L and 275.0 
± 487.4 UI/L respectively. Calves with IgG concentration less than 10g/L, and therefore affected 
by ITPI were 18 (41.86%). 
ROC curves for sTP and GGT activity are shown in figure 1. The cut-off points found for sTP and 
GGT activity were 57 g/L and 151,5 UI/L respectively, while the AUCs were 0.79 (CI 95% 0.65-
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0.94) for sTP and 0.85 (CI 95% 0.73-0.97) for GGT activity. The Se, Sp, PPV, NPV, and accuracy 
with cut off points calculated with ROC curves and with cut-off points presented in literature were 
summarized in table 3. The positive calves with sTP cut-off point of 55 g/L (Tyler et al., 1999) were 
19 (44.19%), while positive calvess with a cut-off point of 57 g/L were 20 (46.51%). The calves 
with a GGT activity of less than 50 UI/L (Tyler et al., 1999) were 8 (18.6%), in contrast, the positive 
calves with cut-off points of 151,50 UI/L were 23 (53.49%). 
Interactions were found between sTP and IgG (p 0.000) and the dehydration degree (p 0.022). For 
the GGT activity, interaction was found with IgG (p 0,003) and age of calves (p 0.010). On the 
basis of these results, data was split for dehydration and age as shown in table 2 and ROC curves, 
Se, Sp, PPV, NPV, and accuracy were calculated again.  
The ROC curves and AUC for sTP in normohydrated calves and in calves with dehydration are 
reported in figure 2. The cut-off points found were 52 g/L and 56 g/L in normohydrated calves 
and dehydrated calves respectively. The Se, Sp, PPV, NPV, and accuracy for these cut-off points 
are reported in table 4. Normohydrated calves which resulted positive to the test were 5/10 (50%), 
while dehydrated positive calves were 13/33 (39.39%). 
The ROC curves and AUC for GGT activity in 5-day old calves or less and in calves older than 5 
days are reported in figure 3. The cut-off points found were 295 UI/L and 100,5 UI/L in calves 
with age ≤ 5 days and > 5 days respectively. The Se, Sp, PPV, NPV, and accuracy for these cut-off 
points are reported in table 4. The calves with an age ≤ 5 days and positive to the test were 8/17 
(47.06%), while calves positive with an age > 5day were 14/26 (53.85%). 
 
Discussion  
In our diarrheic calves, the prevalence of ITPI was 41,86%. Fecteau et al.22 found an ITPI of 86% 
in calves considered sick due to the presence of watery feces, dehydration, depression, injected 
scleral vessels or umbilical infection, while Tyler et al.12 showed an ITPI prevalence of 56% in 
calves with diarrhea, septicemia, hypoglycemia, and hypothermia. Compared to our results, the 
greatest prevalence in the studies of Fecteau et al.22 and Tyler et al.12 could be attributed to the 
effect of ITPI as a risk factor for all the diagnoses included in their study, this type of sample 
obviously altered the frequency with which we saw calves affected by ITPI, increasing the cases 
seen and therefore the prevalence of the condition. Therefore, it is reasonable to expect a lower 
prevalence of ITPI when only selecting calves with NCD as opposed to studies that have included 
all ITPI-related diseases.  
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The sTP cut-off value of 57 g/L of sTP measured using a refractometer, was found to best 
discriminate between diarrheic calves with ITPI and those with a normal value of serum IgG. This 
finding is consistent with that of Tyler et al.12 who used the cut-off point of 55 g/L. This slight 
difference could be attributed to the fact that in our study most of the affected calves had a 
dehydration rate of more than 5% of their BW (33/43), while in the study of Tyler et al.12 the 
dehydration status of the calves enrolled was unknown. Furthermore, Tyler et al.12 had chosen the 
cut-off a priori without the construction of the ROC curve. Sensitivity, specificity, and accuracy of 
the sTP measured by hand-held refractometer for the diagnosis of ITPI were lower than previously 
reported, in both healthy and sick calves11,12,16. Cuttance et al.16 obtained an AUC of 0.99 which 
indicates an excellent ability of sTP to discriminate between calves with ITPI and calves with an 
adequate passive immunity transfer. The differences between our results and those of Cuttance et 
al.16 may be attributed to the epidemiological	differences	between the studies. Cuttance et al.16 
included healthy calves while, in our study, the influence of NCD on sTP concentration cannot be 
ruled out. In diarrheic calves, serum refractance can worsen because of dehydration or an increase 
in blood	inflammatory proteins11,13. On the other hand, panhypoproteinemia could be present in 
calves affected by NCD due to protein-losing enteritis or gastrointestinal blood loss23. These 
factors, however, can reduce the accuracy of an sTP evaluation when classifying diarrheic calves 
with or without ITPI. The regression linear models used underlined an association between the 
sTP concentration and the degree of dehydration. The increase of proteinemia due to dehydration 
was already reported12,13. The evaluation of the accuracy of sTP in normohydrated calves and 
dehydrated calves was adopted to gain a detailed understanding of this issue. By separating the 
calves according to their dehydration status (normohydrated vs. dehydrated calves) we have 
obtained an increase in specificity, but a reduction in sensitivity. The increase in false positive cases 
may be explained by the fact that although some diarrheic calves have an adequate amount of IgG, 
they tend to lose other serum proteins. As	previously	mentioned,	this condition could be explained 
by the panhypoproteinemia that could affect animals with diarrhea due to sepsis, protein-losing 
enteritis, gastrointestinal blood loss, disseminated intravascular coagulation and peritonitis, which 
are closely correlated with NCD 23,24. These findings suggest that the use of sTP measured with a 
refractometer to assess passive transfer in diarrheic calves is not advisable, also considering the 
influence of dehydration. 
One unanticipated finding was the lack of association between the hematocrit and sTP 
concentration. 
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These findings suggest that in diarrheic calves, dehydration is not always associated with an increase 
in the volume percentage of red blood cells. This result could be explained by the high variability 
of the hematocrit during the first weeks of life in calves due to subnormal iron serum concentration 
in suckling calves for the first 2 weeks of age25-28 . The ability of the GGT activity test to identify 
ITPI in calves with NCD was good (AUC 0.84). The general cut-off point in our diarrheic calves 
resulted in 151,5 UI/L with an accuracy, Se, and Sp of 0.89, 0.72 and 0.79 respectively. Based on 
the observation that serum GGT activity may change greatly with age17, two age class variables (≤5 
and >5 days of age) were evaluated to determine the effect of the combination of GGT activity and 
age on the accuracy in diagnosing ITPI. Previous research has established that in 1-day-old healthy 
calves, serum GGT activity should be more than 200 IU/L, in 4-day-old calves more than 100 IU/L, 
in 1-week-old calves more than 75 IU/L15. Cuttance et al.16 have found different cut-offs in healthy 
calves younger than 5 days of age and in animals between 5 and 8 days of age (250 IU/L and 210 
IU/L respectively). The results of our study show that the cut-off value of 295 IU/L of GGT serum 
activity was found to best discriminate ≤5-days-old diarrheic calves with ITPI, while 100,5 IU/L, 
with a reduction of accuracy compared to ≤5-days-old calves, was found to best discriminate >5-
days-old calves with ITPI. These results were in accord with the literature and underline both the 
age-related decrease of serum GGT activity and the decrease of the accuracy of the test in older 
calves15-17. The discrepancy in cut-off values in older calves could be attributed to 
the	high	variability	of serum GGT during its physiological decline over the first 2 months of life 29. 
These findings underline the higher ability of GGT, compared to sTP, to evaluate the transfer of 
passive immunity in calves affected by NCD. Our result agrees with Tyler et al.12, that identified 
the GGT activity test as the most accurate method to identify ITPI in sick calves. 
The major limitation of this study is the small sample size, which means that the results obtained 
can only be used as an indication. Future studies with a higher number of calves could produce 
more reliable and predictive results in determining the transfer status of passive immunity. Also, 
with a higher number of calves, a mathematical model could be built with correction factors 
related to dehydration and also increase the accuracy of sTP to better identify NCD calves with 
ITPI.   
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Table 1. Description of clinical estimation of dehydration proposed by Boccardo et al. (2017) used 
for statistical analysis in calves with neonatal calf diarrhea 
Dehydration degree  
0 Normal hydration, upper eyelid skin tent <2 s 
1 Moderate dehydration, eyeball slightly sunken (1–2 mm), and upper eyelid skin 
tent >2 s but <4 s (estimated loss of body mass 3–5%) 
2 
Obvious dehydration, sunken eyes (3–4 mm), dry nose, upper eyelid skin tent >5 
s (estimated loss of body mass 6–8%) 
3 
Severe sunken eyes with an easily perceptible distance between the eyeball and 
the eyelid (³5 mm), cold ears, legs and oral cavity, dry mouth and nose, upper 
eyelid skin tent persists (estimated loss of body mass ³9%) 
 
Table 2. Classification of predictors for the statistical analysis in case of interaction with serum total 
protein or gamma-glutamyl-transferase. 
Classes Findings 
Dehydration 
0 Normal hydration  
1 Dehydration degree 1 or more 
Hematocrit  
0 < 18% 
1 18-30%, reference range 
2 >30% 
Age of calves  
0 ≤ 5 days  
1 > 5 days  
 
Table 3. Test results for two indirect methods to identified calves with ITPI and concurrent NCD. 
The test used were serum total protein (sTP; g/L) and gamma-glutamyl transferase activity (GGT; 
UI/L). Cut-off points resulted from literature (Ref) or from receiver operating characteristic (ROC) 
curves analysis.  
Cut-points Sensitivity (95%CI) Specificity ((95%CI) PPV (95%CI) NPV (95%CI) Accuracy (95%CI) 
sTP  
Ref* 55 0.72 (0.47 to 0.90) 0.83 (0.61 to 0.95) 0.77 (0.56 to 0.89) 0.79 (0.64 to 0.89) 0.78 (0.62 to 0.89) 
ROC 57 0.78 (0.52 to 0.94) 0.76 (0.55 to 0.91) 0.70 (0.53 to 0.83) 0.83 (0.66 to 0.91) 0.77 (0.61 to 0.88) 
GGT  
Ref* 50 0.58 (0.37 to 0.77) 0.96 (0.89 to 0.99) 0.94 (0.68 to 0.99) 0.69 (0.58 to 0.77) 0.76 (0.63 to 0.87) 
ROC 151.5 0.89 (0.65 to 0.98) 0.72 (0.51 to 0.88) 0.70 (0.54 to 0.81) 0.90 (0.70 to 0.97) 0.79 (0.64 to 0.90) 






Table 4. Test results for two indirect methods to identified calves with ITPI and concurrent NCD. 
The test used were serum total protein (sTP; g/L) spilt for presence or absence of dehydration and 
gamma-glutamyl transferase activity (GGT; UI/L) split for the age of calves (≤ 5 days or >5 days). 
Cut-off points resulted from receiver operating characteristic curves analysis. 
Cut-points Sensitivity (95%CI) Specificity ((95%CI) PPV (95%CI) NPV (95%CI) Accuracy (95%CI) 
sTP in normohydrated calves  
52 0.60 (0.15 to 0.95) 1.00 (0.48 to 1.00) 1.00  0.71 (0.46 to 0.88) 0.80 (0.44 to 0.97) 
sTP in calves with dehydration degree ≥ 1 
56 0.58 (0.39 to 0.91) 0.80 (0.56 to 0.94) 0.69 (0.47 to 0.85) 0.80 (0.63 to 0.90) 0.76 (0.58 to 0.89) 
GGT in calves with age ≤ 5 days  
295 1.00 (0.48 to 1.00) 0.75 (0.48 to 0.93) 0.56 (0.35 to 0.74) 1.00  0.81 (0.58 to 0.95) 
GGT in calves with age > 5 days 





















Figure 1. Receiver operating characteristic (ROC) curves used to calculate the optimal cut-off 
points for diagnosing inadequate transfer of passive immunity in dairy calves affected by neonatal 



















Figure 2. Receiver operating characteristic (ROC) curves used to calculate the optimal cut-off 
points for diagnosing inadequate transfer of passive immunity in dairy calves affected by neonatal 
calf diarrhea using serum total protein (sTP; g/L) in normohydrated calves (a) and in dehydrated 
calves (b). The area under the curve (AUC) for the first ROC (a) was 0.84 (95% CI 0.58 to 1.00), 
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Figure 3. Receiver operating characteristic (ROC) curves used to calculate the optimal cut-off 
points for diagnosing inadequate transfer of passive immunity in dairy calves affected by neonatal 
calf diarrhea using gamma-glutamyl transferase activity (GGT; UI/L) in calves with age of 5 days 
or less (a) and in calves with age more than 5 days (b). The area under the curve (AUC) for the first 
ROC (a) was 0.78 (95% CI 0.53 to 1.00), while the AUC for the second ROC (b) was 0.87 (95% 
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Abstract 
The aim of this retrospective study was to identify the major risk factors associated with case fatality 
in diarrheic calves undergoing a standard therapeutic protocol. Clinical and laboratory findings 
were reviewed in 225 Holstein Friesian diarrheic calves over a 2 year period. Calves were treated 
according to a fluid therapy protocol using an oral electrolyte solution or an IV infusion. After 
therapy, 159 calves were discharged in a healthy state, whereas 66 calves died. Logistic regression 
analysis showed that serum total protein (STP) concentration (odds ratio, OR, 0.51; 95% 
confidence interval, CI 0.31–0.84; P < 0.01) and the strength of suckle reflex (OR 4.83; CI 1.17–
19.88; P < 0.05) were the major risk factors associated with case fatality in diarrheic calves. These 
results could help to distinguish between diarrheic calves with a good prognosis and those with a 
major risk of treatment failure. 
 
Neonatal calf diarrhea (NCD) is the most common cause of morbidity and mortality in pre-weaning 
dairy calves. Few studies have focused on risk factors associated with case fatality in affected calves. 
Previous research has established that blood urea nitrogen, packed cell volume (PCV), blood 
chloride (Cl _), potassium (K+) and creatinine concentrations are the most important prognostic 
factors for diarrheic calves (Fayet and Overwater, 1978; Klee et al., 1979; Wiest and Klee, 1998; 
Seifi et al., 2006). A model capable of predicting case fatality in diarrheic calves could help to 
identify calves with a high case fatality risk and to select the optimal therapeutic protocol. The aim 
of this study was to review clinical and laboratory findings in diarrheic calves referred to the Clinic 
for Ruminants and Swine, University of Milan, Italy, to identify major risk factors associated with 
NCD case fatality risks in calves treated with a standard therapeutic protocol. The clinical records 
of calves, 28 days old and diagnosed with NCD from 1 January 2014 to 31 December 2015, were 
assessed retrospectively. The presence of other concurrent diseases at admission was used as an 
exclusion criterion. Clinical (Table 1) and laboratory values were determined on arrival. After 
admission, calves were housed in individual pens bedded with straw. Fresh water, hay and calf 
starter were offered ad libitum. Calves were fed 2 L of milk replacer (Solvor MG + Instant, Bonilait) 
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three times daily. Fluid therapy was performed according to a standard protocol (Table 2). The 
required amount of sodium bicarbonate was adjusted for each calf and calculated as: bicarbonate 
(g) = body weight (kg) _ base excess (mmol/L) _ 0.6 (L/kg) _ 0.084 (g/mmol). Calves with a history 
of malnutrition for more than 12 h received 400 mL of 50% glucose solution added to the saline 
solution. On the day of admission, all calves received flunixin meglumine IV (Alivios, Fatro) at a 
dose of 2.2 mg/kg. Amoxicillin– _clavulanic acid (Synulox, Zoetis) was administered SC at a dose 
of 10 mg/kg for 5 days. Logistic regression was used to identify risk factors that were statistically 
associated with case fatality. Initially, the fitted model included all available clinical variables, both 
categorical and continuous, as fixed effects (Table 3). Month of admission and therapeutic protocol 
were also included (Table 2). Previous studies reported that STP is associated with neonatal 
mortality (Biffani et al., 2015) and that STP may change appreciably with age, even if it remains 
approximately constant for the first week of life (Boccardo et al., 2016). Therefore, age class (7 and 
>7 days) was included in the model to evaluate its interaction with STP. No additional interaction 
was added to the model because preliminary tests, in which interaction terms between STP and 
categorical traits other than age class were fitted, indicated that this would have caused model over-
fitting, most probably because of limitations in sample size. No multicollinearity was detected using 
the variable inflation factor and Durbin-Watson tests. McFadden’s pseudo-R2 of the full model 
was 0.30. Variables identified as potentially useful predictors based on a P value <0.1 were used in 
a final model to estimate the probability of surviving or dying. On the basis of our selection criteria, 
225 Holstein calves (22 male, 203 female) were included in this study. Therapeutic results and 
medical data are summarised in Tables 2 and 3. Of all considered variables, STP concentration 
(odds ratio, OR, 0.51; 95% confidence interval, CI 0.31–0.84; P < 0.01) and absence of suckle 
reflex (OR 4.83; CI 1.17–19.88; P < 0.05) were the only two risk factors significantly associated 
with case fatality. The interaction between STP and age did not present a significant case fatality 
risk (OR 0.88; CI 0.71–1.07; P = 0.20). Our results showed that a low STP concentration is 
significantly associated with case fatality in diarrheic calves. STP concentration is commonly used 
for the evaluation of the transfer of passive immunity in healthy and clinically ill young calves. Our 
findings suggest that failed transfer of passive immunity (FTPI) is associated with decreased 
effectiveness of the therapeutic protocol. In addition to FTPI, especially in diarrheic calves >1 week 
of age, other causes of hypoproteinaemia cannot be ruled out. This result may be explained by the 
fact that hypoproteinaemia is often a consequence of critical illnesses including sepsis, protein-
losing enteritis, gastro-intestinal blood loss, disseminated intravascular coagulation and peritonitis, 
which are all closely correlated with NCD (Fecteau et al., 1997; Morris and Johnston, 2009). 
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Another interesting finding is the observation that the absence of a suckle reflex is associated with 
an increased case fatality risk. Although most neurological disturbances in diarrheic calves are 
related to D-lactate accumulation in the cerebrospinal fluid, the strength of the suckle reflex is 
depressed by D-lactic acidosis and by a reduced cerebrospinal fluid bicarbonate concentration 
(Abeysekara et al., 2007). However, the current study indicates that the acid–base imbalance does 
not contribute significantly to the case fatality risk. These contradictory results are consistent with 
data obtained in human and animal model studies (Latronico et al., 2005) and may be explained 
by the fact that, irrespective of alkalinisation and rehydration, severe neurological complications 
may persist in critically ill calves, thus reducing the muscle tone necessary for suckling. In the 
present study, STP concentration and lack of suckle reflex were significantly associated with case 
fatality risks in dairy calves with NCD receiving a fluid therapy protocol. This finding may help 
veterinary practitioners to determine the prognosis for calves with NCD based on inexpensive and 
easy-to-obtain clinical and laboratory parameters.  
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Table 1. Description of clinical score used for the evaluation of the vigour, degree of dehydration, 
and strength of the suckle reflex. 
Score Clinical signs 
Vigour  
5 Standing securely without assistance, curious, alert. 
4 Standing up after encouragement, weak, “sad calf”. 
3 Sternal recumbency, standing after lifting, “drunken gait’’, insecurely 
posture. 
2 Permanent sternal/costal recumbency. 
1 Lateral recumbency, sometimes comatose. 
  
Dehydration  
0 Normal hydration, upper eyelid skin tent <2 s. 
1 Moderate dehydration, eyeball slightly sunken (1-2 mm), and upper eyelid 
skin tent >2 s but <4 s (estimated loss of BW= 3-5%). 
2 Obvious dehydration, sunken eyes (3-4 mm), dry nose, upper eyelid skin 
tent >5 s (estimated loss of BW= 6-8%). 
3 Severe sunken eyes with an easily perceptible distance between the eyeball 
and the eyelid (≥5 mm), cold ears, legs and oral cavity, dry mouth and 
nose, upper eyelid skin tent persists (estimated loss of BW= ≥9%) 
  
Suckle reflex  
0 Strong 
1 Weak 
2 Absent or chewing movements 
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Table 2. Therapeutic results of 225 calves assigned to a treatment standard protocol based on 
clinical and acid-base status. 















(ORS) (n = 16 
calves)a 




refuse ORS (n = 17 
calves) b 
5 L isotonic saline + 
8.4% NaHCO3 (n = 
67 calves) c 
10 L isotonic saline + 
8.4% NaHCO3 (n = 
125 calves) d 
First fluid protocol     
Clinical improvement after first 
fluid/ORS protocol 16 (s) 12 (s) 38 (s) 72 (s) 
Sudden death during first fluid/ORS 
protocol - - 3 (d) 6 (d) 
Sudden death after first fluid/ORS 
protocol - - 5 (d) 12 (d) 
Euthanasia during first fluid/ORS 
protocol due to severe concurrent 
diseases 
- - 5 (d) 4 (d) 
Euthanasia after first fluid/ORS 
protocol due to severe concurrent 
diseases 
- - - 3 (d) 
     
Unresponsive calves      
No clinical improvement 12-24h after 
therapy - - 5 10 
Deterioration of the general 
conditions after a primary 
improvement 
- 5 11 18 
     
Fate and management of unresponsive 
calves     
Calves further subjected to fluid and 
bicarbonate therapy according to their 
clinical and acid-base status. 
- 5 12 24 
Unresponsive not dehydrated calves 
without acid-base disorders not 
subjected to fluid therapy 
- - 4 (d) 4 (d) 
Calves that experienced clinical 
improvement after the second 
infusion. 
- 4 (s) 6 (s) 11 (s) 
Sudden death during/after secondary 
fluid protocol - - 3 (d) 7 (d) 
Euthanasia due to severe concurrent 
disease after secondary fluid protocol - 1 (d) 3 (d) 6 (d) 
 
(s) surviving calves (n = 159 calves), (d) dead calves (n = 66 calves) 
a Diarrheic calves with strong suckle reflex, vigour score ≥4, dehydration score ≤1, base excess up to -8 mmol/L received on 
admission 1 L of ORS containing 4 g sodium chloride, 20 g dextrose, 3 g potassium bicarbonate and 3 g sodium propionate. One 
L of ORS was additionally administered three times between milk feedings	during	the	first	24	h	after	admission. 
b Calves that did not completely drink ORS at the time of admission or between milk feedings received a constant drip infusion 
consisting of 5 L of isotonic saline spiked with 8.4% NaHCO3 at slow infusion rate (10 mL/kg/h). 
c Calves with vigour score <4, or dehydration score >1 or base excess < -8 mmol/L received a constant drip infusion consisting of 5 
L of isotonic saline spiked with 8.4% NaHCO3 at slow at constant drip infusion (40 mL/kg/h).  



















P value *, P <0.05; P value **, P <0.005 
a Serum total protein concentration was determined with a colorimetric assay (Total Proteins 
Quantitative Colorimetric Assay; Biochemical Enterprise) following the manufacturer’s protocol. 
The results of the colorimetric assay were determined using a clinical chemistry analyser (Roche 
Cobas Mira Classic; Hoffmann-La Roche). 
b Venous blood gas parameters were determined using a blood pH gas-analyzer (AVL Opti CCA; 
Diamond Diagnostic). 
c 225 calves were assigned to a treatment standard protocol based on clinical and acid-base status. 
See Table 2 for details. 
  
Variables Mean values±SD  
 Surviving calves Dead calves P value 
Sex   0.88 
Body weight (kg) 42.8±5.9 43.0±5.6 0.70 
Age at hospitalization (days) 8.84±4.9 11.0±5.4 0.27 
Duration of clinical signs prior to admission (days) 2.3±1.9 2.7±2.2 0.69 
Month of hospitalization (1-12)   0.13 
Dehydration score (0-3) 1.7±0.8 1.9±0.8 0.99 
Vigour score (1-5) 2.8±1.0 2.4±1.1 0.99 
Suckle reflex (0-2) 0.7±0.7 0.9±0.8 0.0293* 
Rectal temperature (°C) 38.4±1.3 37.8±1.8 0.99 
Serum total protein (g/L)a 57±13 48±12 0.008** 
pH b 7.2±0.1 7.1±0.2 0.36 
Partial pressure of carbon dioxide (mmHg) b 43.4±11.1 44.6±11.5 0.55 
Blood bicarbonate (mmol/L) b 16.8±7.4 16.5±7.6 0.52 
Base excess (mmol/L) b -10.9±9.0 -11.9±9.3 0.54 
Blood sodium (mmol/L) b 131.5±13.5 130.7±14.6 0.59 
Blood potassium (mmol/L) b 5.7±1.7 5.5±1.7 0.50 
Blood chloride (mmol/L) b 103.3±11.3 104.6±14.2 0.50 
Anion gap (mmol/L) b 17.1±6.2 16.3±5.8 0.41 
Packed cell volume (%)b 33.9±8.7 33.3±8.2 0.20 
Haemoglobin (g/dL) b 10.9±2.9 11.0±3.0 0.48 
Therapeutic protocol (1-4)c   0.99 
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Neonatal Calf Diarrhea (NCD) is a multifactorial disease that causes severe economic losses due to 
mortality, treatment cost and poor growth. The clinical presentation of NCD is characterized by 
liquid feces, dehydration, metabolic acidosis, alterations in posture, behavior and hypovolemic 
shock. Therefore, the aim of the treatment is to correct hydration and acid-base imbalance with 
fluid therapy. Antibiotic treatment is commonly recommended regardless of the pathogen 
involved, but the real efficacy of its use is controversial. This study investigates the efficiency of 
antibiotics during NCD and their influence on gut microbiota, considering the immunity status of 
the calf. 
Forty-two Holstein Friesian calves with NCD, aged from 1 to 28 days were enrolled, excluding 
those with other concurrent neonatal diseases. Upon admission, dehydration was estimated as body 
weight percentage and the acid-base imbalance was assessed by venous blood-gas analysis. 
Furthermore, the immunity status was investigated using serum total protein and the calves were 
then split into two groups depending on the presence, absence or inadequate transfer of passive 
immunity (ITPI). For each group, calves were randomly assigned to the antibiotic group (Group 
A) or to the antibiotic-free group (Group FA). The 4 groups obtained were group A1 (NCD calves 
with antibiotic administration), group FA1 (NCD calves without antibiotic administration), group 
A2 (NCD calves with ITPI and treated with antibiotics), group FA2 (NCD calves with ITPI and 
treated without antibiotics). Group A1 and A2 received ampicillin (10 mg/kg IV q12h for 5 days), 
a wide spectrum antibiotic as the antibiogram results were delayed. Group A2 and FA2 received 
hyperimmune plasma as a treatment for ITPI. Each calf was monitored for 28 days. Calf Health 
Scoring Chart (CHSC), average daily gain and sepsis score were recorded daily. Calves of both 
groups whose general conditions deteriorated (sepsis score > 60%) were given an antibiotic based 
on antibiotic susceptibility tests. Furthermore, the microbiota analysis was performed.  
The results showed no statistical difference for mortality rate, failure of treatment, average daily 
gain and days with diarrhea between the groups treated with or without antibiotics, regardless of 
presence or absence of ITPI. Furthermore, the antibiotic treatment was found to be associated 
with a worsening of the fecal score and scleral vessels. The microbiota analysis showed that the 
microbiota of calves treated without antibiotics was re-established earlier than calves treated with 




Parenteral administration of broad-spectrum-lactam antimicrobials or potentiated sulphonamides 
is recommended for treating calves with neonatal calf diarrhea (NCD) with systemic illness and 
concurrent inadequate transfer of passive immunity (ITPI)1. However, antibiotic therapy may not 
be beneficial in many cases, as in the case of NCD due to viruses or parasites, which may result in 
longer recovery times2. Calves treated prophylactically for calf diarrhea during the first two weeks 
of life with antibiotic treatment in the milk had lower weight gain, lower feed intake, and more 
days with diarrhea than calves not receiving antibiotics in the milk2. Furthermore, treating calves 
with unnecessary antibiotics increases antimicrobial resistance and environmental contamination 
with its compounds3,4. As well as this, antibiotic treatment, along with NCD, can disrupt the gut 
microbiota of calves, influencing the re-establishment of the normal microbiota and predisposing 
the calves to relapses5-7. Despite that, in Italy, the practitioner systematically uses antibiotics in 
cases of NCD8. For the treatment of ITPI and subordinated diseases, such as NCD, parenteral 
administration of fresh frozen plasma, serum, or whole blood have been empirically 
recommended9,10.  
Testing the real efficiency of the antimicrobial treatment in NCD is important to unify the therapy 
protocol of NCD and to reduce unnecessary antibiotic treatments. Despite current attention and 
research on the gut microbiota, few population-based studies have been conducted in cattle to 
better understand how the microbiota is impacted during NCD. 
Therefore, this study aims to evaluate the efficiency of antibiotics during NCD and their influence 
on the gut microbiota, considering the immunity status of the calf. Mortality rate, growth rate in 
survivors, and duration of diarrhea were used to evaluate the success of therapy.  
Materials and methods 
Calves and experimental design  
The present study was approved by the Ministry of Health (approval number 14/2018). 
Forty-two NCD calves were selected, between the client-owned dairy calves admitted to the Clinic 
for Ruminant and Swine (CTS)-Veterinary Teaching Hospital of the University of Milan from May 
2018 to May 2019, included in the study and monitored for 28 days. At admission, complete 
physical examinations followed a standardized protocol and were carried out at the time of 
admission by one of the main authors belonging to the CRS. Only Holstein Frisian calves with 
clinical diagnosis of NCD aged between 1 and 28 days were included in the study. The diagnosis 
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was based on the presence of watery feces and NCD-related symptoms such as dehydration, 
metabolic acidosis, alterations in posture or behavior. Animals older than 28 days, belonging to 
other breeds, with other concurrent diseases or treated before admission were excluded.  
On admission, diarrheic calves were weighed (Omega Twin 3, Omega Bilance S.r.l, Varese, Italy), 
and submitted to a complete clinical examination and laboratory tests. To allow an objective 
analysis, the modified calf health scoring chart (CHSC, table 1) was used to record clinical data. A 
blood sample for venous blood-gas analysis was also anaerobically collected from the jugular vein 
into a disposable heparinized 2.5 mL syringe. Blood pH, bicarbonate (HCO3⁻), partial pressure of 
carbon dioxide (pCO2), base excess (BE), blood sodium (Na⁺), chlorine (Cl⁻), potassium (K⁺) and 
anion gap (AG) were immediately determined using a blood gas analyzer (Epoc blood analysis, 
Epocal Inc., Ottawa, Canada). A second blood sample was collected in a 9-mL tube without 
anticoagulant from the jugular vein and used to determine serum total proteins (sTP). Samples 
were allowed to clot and then centrifuged at 20 °C for 10 min at 900 g. The serum obtained was 
used immediately to measure the concentration of serum total protein (sTP) and then stored for 
further determination of immunoglobulin G (IgG). The concentration of sTP was used to divide 
calves with ITPI from calves with adequate transfer of passive immunity (ATPI) using the cut-off 
point reported by Tyler et. al10 for sick calves (calves with ITPI: sTP ≤55 g/L; calves with ATPI: 
sTP > 55 g/L). For each group, calves were randomly assigned to the antibiotic group (Group A) 
or to the antibiotic-free group (Group FA). Resulting groups involved in the study were composed 
as follows: 
Group A1 (n.=12): animals affected by NCD with ATPI (sTP > 55 g/L), with antibiotic 
administration 
Group FA1 (n.=12): animals affected by NCD with ATPI (sTP > 55 g/L), without antibiotic 
administration 
Group A2 (n.=9): animals affected by NCD with ITPI (sTP < 55 g/L), with antibiotic 
administration 
Group FA2 (n.=9): animals affected by NCD with ITPI (sTP < 55 g/L), without antibiotic 
administration 
Fecal antibiotic susceptibility tests were also done. Furthermore, fecal samples were collected and 
stored for the microbiota analysis.  
Fluid therapy and anti-inflammatory treatment was performed according to a standard protocol11.  
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Calves from groups A1 and A2 received ampicillin at a dose of 10 mg/kg IV q12h for 5 days 
(Vetamplius, Fatro, Ozzano dell'Emilia, Italy) a wide spectrum antibiotic, as described by 
Constable (2004), as the antibiogram results were delayed. Calves from groups A2 and AF2 
received hyper immune plasma transfusion (PlasmaLife Calf*) for the treatment of ITPI as 
recommended by Weaver et al.9 and Tyler et al.10. The quantity of plasma was calculated with the 
following formula: PlasmaLife Calf= (BW × plasma volume × sTP GAP)/(sTP concentration) 
where BW=body weight (Kg); plasma volume =8,9% of body weight; sTP GAP= difference 
between pre–transfusion sTP and desired post–transfusion sTP (60 g/L); sTP concentration= 
concentration of sTP in the plasma declared by the producer (IL CEPPO S.a.s). 
Monitoring of calves 
During the study period, calves were housed in individual calf brick pens (1.8 m × 1.2 m) in an 
indoor 30- place stall with a controlled temperature of 18 °C. The pens were bedded with straw 
and cleaned every day. After the reappearance of the suckle reflex, 2 L of milk replacer were offered 
three times a day. Freshwater, hay and calf starter were offered ad libitum.  
Uniform treatment and clinical procedures were ensured by daily patient rounds performed by at 
least one experienced clinician. Calves were monitored daily with complete clinical examinations. 
The clinical data was recorded using CHSC and the probability of sepsis was calculated as 
described by Fecteau et al.12. Calves of all groups, whose general conditions deteriorated (sepsis 
probability >60%), were given an antibiotic based on antibiotic susceptibility tests and treated with 
further IV fluid therapy based on their current acid–base and dehydration status. This event was 
considered as a failure of therapy. On the 2ndday of hospitalization every calf was weighed, and a 
blood sample was collected. On the 7th, 14th, 21stand 28thday of hospitalization in addition to the 
weighing and blood collection, a fecal sample was collected. The serum obtained by centrifugation 
was analysed to measure the concentration of sTP and of IgG, while the feces were used for 
microbiota analysis.  
 
 
*PlasmaLife Calf® (IL CEPPO S.a.s. Via Monteresi, 3 – 53035 Monteriggioni (SI) Italia - P.IVA 00896660529) is frozen fresh 
plasma stored in 300 mL bags. The producer declares a quantity of total protein between 50 and 90 g/L. The plasma is obtained by 
cows free of brucellosis, tuberculosis, leucosis, Infectious Bovine Rhinotracheitis and Bovine Viral Diarrhea and immunized against 
Escherichia coli F5, Bovine Rotavirus and Bovine Coronavirus. PlasmaLife Calf® is produced by plasma filtration process and 
stored in 300 ml PVC bags for emotransfusion products. The plasma is attending the commercial authorization (A.I.C). 
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Serum analysis, microbiota sequencing and analysis 
The serum collected from each of the 43 calves at six different time points was used when fresh for 
the measurement of the sTP and stored at – 20°C until determination of IgG concentration. The 
sTP concentration was measured by handle refractometer by the same operator (GS). Serum IgG 
was determined by radial immunodiffusion using a bovine IgG commercial kit (Bovine IgG Test 
Kit Radial Immunodiffusion Test Kit, Triple J Farms, Washington, USA) according to the 
manufacturer’s instructions.  
Fecal samples were collected from each of the 43 calves at five different time points and were stored 
at − 20 °C until DNA extraction was performed. DNA was extracted from each fecal sample using 
a QIAmp DNA Stool kit (Qiagen, Hilden, Germany), according to the manufacturer’s protocol. 
DNA quality and quantity were assessed using a NanoDrop ND-1000 spectrophotometer 
(NanoDrop Technologies, Wilmington, DE, USA). The isolated DNA was then stored at -20°C 
until use. 
Bacterial DNA was amplified using the primers described in literature (Caporaso et al., 2011) 
which target the V3-V4 hypervariable regions of the 16S rRNA gene. All PCR amplifications were 
performed in 25 μl volumes per sample. A total of 12.5 μl of KAPA HIFI Master Mix 2× (Kapa 
Biosystems, Inc., MA, USA) and 0.2 μl of each primer (100 μM) were added to 2 μl of genomic 
DNA (5 ng/μl). Blank controls (no DNA template added to the reaction) were also performed. A 
first amplification step was performed in an Applied Biosystem 2700 thermal cycler (ThermoFisher 
Scientific). Samples were denatured at 95°C for 3 min, followed by 25 cycles with a denaturing step 
at 98°C for 30 s, annealing at 56°C for 1 min and extension at 72°C for 1 min, with a final extension 
at 72°C for 7 min. Amplicons were cleaned with Agencourt AMPure XP (Beckman, Coulter Brea, 
CA, USA) and libraries were prepared following the 16S Metagenomic Sequencing Library 
Preparation Protocol (Illumina, San Diego, CA, USA). The libraries obtained were quantified by 
Real Time PCR with KAPA Library Quantification Kits (Kapa Biosystems, Inc., MA, USA), pooled 
in equimolar proportion and sequenced in one MiSeq (Illumina) run with 2×250-base paired-end 
reads. 
Demultiplexed paired-end reads from 16S rRNA-gene sequencing were first checked for quality 
using FastQC13 for an initial assessment. Forward and reverse paired-end reads were joined into 
single readings using the C++ program SeqPrep14. After joining, readings were filtered for quality 
based on: i) maximum three consecutive low-quality base calls (Phred < 19) allowed; ii) fraction of 
 69 
consecutive high-quality base calls (Phred > 19) in a read over total read length ≥0.75; iii) no “N”-
labeled bases (missing/uncalled) allowed. Readings that did not match all the above criteria were 
filtered out. All remaining readings were combined in a single FASTA file for the identification 
and quantification of OTUs (operational taxonomic units). Readings were aligned against the 
SILVA closed reference sequence collection release 123, with 97% cluster identity15,16, applying 
the Cd-hit clustering algorithm17. A pre-defined taxonomy map of reference sequences to 
taxonomies was then used for taxonomic identification along the main taxa ranks down to the 
genus level (domain, phylum, class, order, family, genus). By counting the abundance of each OTU, 
the OTU table was created and then grouped at each phylogenetic level. OTUs with total counts 
lower than 15 in fewer than 2 samples were filtered out. All of the above steps, except the FastQC 
readings quality check, were performed with the QIIME open-source bioinformatics pipeline for 
microbiome analysis18. The fecal microbial diversity was assessed within samples (alpha diversity). 
All indices (alpha and beta diversity) were estimated from the complete OTU table (at the OTU 
level), filtered for OTUs with more than 15 total counts distributed in at least two samples. Besides 
the number of observed OTUs directly counted from the OTU table, within-sample microbial 
richness, diversity and evenness were estimated using the following indices: Chao1 and ACE 
(Abundance-based coverage Estimator) for richness, Shannon, Simpson and Fisher’s alpha for 
diversity19-24.  
Statistical analysis 
Sample size assessment for the study was based on the NCD and ITPI design prevalence reported 
in literature. The average prevalence of NCD in USA and Europe25,26 is 19% approximately with 
20% mortality. While the average prevalence of FPT is 30% approximately with 18% mortality27.  
To detect the number of required animals a two-sample t test analysis was applied using G-power 
software (Ver. 3.1, Heinrich-Heine-Universität, Düsseldorf, Germany). To achieve this, a sample 
size of 0.8 (high), αerror of 5% (type I), a confidence interval of 95% and a test power of 80% 
were used. The result was 42 animals. 
For all statistical analysis a commercially available statistical software was used (SPSS 25.0 for Mac, 
IBM, Armonk, USA).  
Descriptive statistics were performed, and continuous variables were expressed as the mean ± SD, 
while categorical variables were expressed as frequencies and percentages.  
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The following analysis were performed first in calves with ATPI (group A1 and group AF1) and in 
calves with ITPI (group A2 and group AF2) independently, and then without considering the 
immune status (group A1, A2 and group AF1, AF2).  
The difference in mortality and failure of treatment between the groups was investigated with a χ2test. The difference of continuous variables (average daily gain and days of diarrhea), after testing 
the normal distribution with Shapiro-Wilk test, between groups was investigated with a Student t 
test. 
Multivariable logistic regression models were fit to determine the effects of antibiotics on the 
clinical and laboratory parameters. After univariable analysis, categorical variables that resulted in 
P ≤0.20 were included as fixed effects in the multivariable model. Categorical variables that were 
checked in the univariable analysis including suckle reflex, fecal score, attitude, hydration, scleral 
vessels, nasal discharge, eye/ear score, cough, and total CHSC.  
Other two multivariable logistic regression models were fit to determine the correlation between 
failure of therapy and mortality, and the clinical and laboratory parameters. After univariable 
analysis, categorical variables that resulted in P ≤0.20 were included as fixed effects in the 
multivariable model. Categorical variables that were checked were the same used for antibiotic 
treatment as explained before. Backwards stepwise elimination was used to reduce the model until 
all remaining variables were significant at the α≤0.05 level.  
Multivariable linear regression models were fit to determine the effects of antibiotics on the clinical 
and laboratory parameters. After univariable analysis, continuous variables that resulted in P≤0.20 
were included as fixed effects in the multivariable model. Categorical variables that were checked 
in the univariable analysis included, weight, sTP and IgG.  
Other two multivariable logistic regression models were fit to determine the correlation between 
failure of therapy and mortality, and the clinical and laboratory parameters. After univariable 
analysis, continuous variables that resulted in P ≤0.20 were included as fixed effects in the 
multivariable model. Continuous variables that were checked were the same used for antibiotic 
treatment as explained before. Backwards stepwise elimination was used to reduce the model until 





Following the selection criteria, 32 female (76.2%) and 10 male (23.8%) Holstein Frisian calves 
with NCD, and not treated before admission to the CRS, were included in this study. The average 
age was 7 ± 4 days. The clinical parameters, sTP concentration, and IgG concentration during the 
study period were summarized in table 2. On admission, the average results of emogas analysis 
were pH 7.28 ± 0.12; pCO2 45.27 ± 9.64 mmHg; HCO3- 21.98 ± 7.85 mmol/L; BE -4.34 ± 9.28 
mmol/L; Na+ 134.67 ± 11.21 mmol/L; K+ 5.56 ± 2.08 mmol/L; Cl- 102.52 ± 12.38 mmol/L; AG 
12.15 ± 4.95 mmol/L. In calves included in the study, the average number of days with diarrhea 
was 7 ± 4, while the average daily gain during the 28 days of observation was 8.7 ± 6.3 kg. The total 
mortality rates and failure of treatment were 14/42 (33.3 %). The percentage of mortality rates and 
failure of treatment in the groups is shown in figure 1.  
No significant difference in mortality rate and failure of treatment were found between groups with 
or without antimicrobial treatment, also considering the presence or absence of ITPI.  
The average daily gain resulted normally distributed, while the days with diarrhea were not 
normally distributed. No difference in average daily gain and days with diarrhea were underlined 
between the groups, independently from undergoing treatment with or without antimicrobials and 
the immunity status.  
Multivariate logistic and linear regression models in calves with and without antibiotic treatment 
This statistical analysis included all calves without considering the immunity status (groups A1, A2 
and groups AF1, AF2).  
The results of multivariate logistic regression models showed an association of antibiotic treatments 
and suckle reflex (p< 0.01), an association of failure of treatment with eye/ear scores (p< 0.01) and 
cough (p <0.01) and an association between mortality and fecal scores (p 0.04), eye/ear scores (p< 
0.01) and cough (p< 0.01). For the other variables, no statistical significance was shown. The 
multivariate linear regression models underline only an association of failure of treatment and IgG 
(p< 0.01). The result for the sTP concentration showed that it did not influence the mortality rate 
and it was similar in groups treated with or without antibiotics.  
Multivariate logistic and linear regression models in calves with ATPI  
This statistical analysis included calves with ATPI divided into two groups according to the 
different treatments (group A1 and group AF1).  
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The multivariable regression models showed an association of antimicrobial treatments with the 
suckle reflex (p 0.02) and scleral vessels (p<0.01), and an association of mortality with attitude 
(p<0.01). No association was found between failure of treatment and clinical parameters in NCD 
calves with ATPI. 
As shown by multivariate linear regression models, sTP and IgG influence the failure of treatment 
in these calves (p 0.020 and p 0.012 respectively).  
Multivariate logistic and linear regression models in calves with ITPI 
This statistical analysis included calves with ITPI divided into two groups according to the different 
treatments (group A2 and group AF2).  
The multivariable regression models showed an association of antimicrobial treatments with fecal 
scores (p<0.01),failure of treatment with eye/ear scores (p< 0.01) and cough (p <0.01) and an 
association of mortality with fecal scores (p< 0.01), nasal discharge (p 0.02), eye/ear scores (p 0.02) 
and cough (p 0.039). No association was underlined by the multivariate linear regression models. 
Microbiota analysis 
The alpha diversity index showed that calves treated without antibiotics had a significant increase 
of richness in the second sample (7 days after the start of the study). The same result was obtained 
with the baseline correction of values (figure 2).  
Forty different phyla were identified: Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria 
accounted for more than 80% of sequences. Changes in the relative abundance of main phyla are 
presented in table 3. The relative abundance of Actinobacteria was significantly higher at the 
second time point in calves without antibiotic treatment.  
Seventy-four different Classes, 98 Orders and 145 Families were identified. The relative 
abundances of the 5 most abundant bacterial taxa (Class, Order, Family) identified in faces of 
calves with and without antibiotic treatment are presented in Tables 3. No significant difference 
was found for the Class and Order between the two groups. The Families Bacteroidaceae, 
Porphyromonadaceae and Rikenellaceae measured at the fourth time point were significantly higher 
in the group treated with antibiotics, while the Family Lachnospiraceae was significantly higher the 






This study investigates the efficacy of antibiotic treatment in calves affected by NCD, and its 
influence on gut microbiota.  
The mortality rate observed during the study period was 33.3%. Previous studies have reported 
that mortality risks for diarrhea ranged from 4.9% to 24% in field conditions 28,29, and 5% to 35% 
in hospital conditions30-32. However, our result showed the same mortality rate in both calves with 
or without ITPI. Fecteau et al.29 and Lofstedt et al.30 showed a higher mortality rate in calves with 
ITPI than calves with high concentration of IgG and sTP: Furthermore, sTP was associated with 
fatality risk11 and, therefore, could increase the mortality rate. The possible explanation is that 
hyperimmune plasma transfusion may lead to a decrease in mortality rates in ITPI calves. 
Failure of treatment, corresponding to a probability of sepsis of more than 60%, was found in 
14/42 calves (33.3%). This result was in concordance with the data reported in literature. Fecteau 
et al. 29 conducted two studies, in which the sepsis was 31% in one study and 24% in the other. 
Lofstedt et al. 30 reported a similar percentage of sepsis (31%) in calves with NCD.  
In our study, the probability of sepsis was identical in both calves with and without ITPI. This 
result was in contrast with the literature. Both studies on the probability of sepsis found a higher 
sepsis rate in calves with ITPI and concurrent NCD29,30. Our results could be explained by the 
administration of hyperimmune plasma that could influence the morbidity and mortality rates. 
Parenteral administration of fresh frozen plasma, serum, or whole blood was empirically 
recommended in calves with ITPI to reduce morbidity and mortality rates9.  
 Statistical analysis showed that antibiotic treatment did not influence mortality rate, failure of 
treatment, average daily gain and days with diarrhea, regardless of the calves’ immunity statuses. 
These results are not fully in agreement with the literature. The data available on the antibiotic’s 
influence on mortality rates are not univocal. Some studies underlined an effective role of 
antibiotics, either administered orally or parenterally, in the decrease of mortality rates33,34, while 
others did not find any difference35-38. In literature it is recommended to use antibiotics in cases of 
NCD with signs of sepsis1,2. The two main indications for the use of antibiotics in NCD are the 
prevention of secondary bacteremia and the reduction in the number of coliform bacteria in the 
small intestine. The effect of antibiotics on average daily gain and days with diarrhea are also 
controversial. Some studies showed a reduction of sick days35,39, while one study did not find a 
difference in days with diarrhea in calves treated with or without antimicrobials40.  
 74 
Berge et al.2 showed that using antimicrobials only in diarrheic calves with fever, inappetence, or 
depression reduces the number of days with diarrhea compared to the administration of antibiotics 
in all cases of diarrhea. The literature results also differ for the growth rate. Berge et al2 underline 
an increase of growth rate in diarrheic calves treated with antibiotics only in cases of sepsis signs 
compared to the conventional use of antimicrobials. In this study, Berge et al.2 also showed that 
calves treated prophylactically for calf diarrhea during the first two weeks of life with neomycin or 
tetracycline in the milk had lower weight gain, lower feed intake, and a higher number of days with 
diarrhea than calves not receiving antibiotics in the milk. Therefore, the other two studies showed 
an increase in growth rates in diarrheic calves treated systematically with antibiotics either 
administered orally or parenterally 33,39. Our results are in contrast with the recommended use of 
antibiotics to reduce mortality rate, sepsis probability, number of days with diarrhea and an 
increase in growth rates suggesting that a targeted fluid therapy can be sufficient alone for the full 
recovery of diarrheic calves.  
The multivariate analysis showed the influence of antibiotics on the suckle reflex, sclera vessels, 
and fecal scores. The effect of antibiotics on the suckle reflex was positive, while the effects on 
sclera vessels and fecal scores were negative. Our result regarding the suckle reflex was also found 
in another study39. In this study, ampicillin trihydrate combined with nitrofurazone for 5 days 
improved the general appearance and the suckle reflex of calves and on day 5 and day 12, when 
compared with non-antimicrobial-treated control calves. The red and increased sclera vessels, were 
considered a sign of endotoxemic shock. The possible explanation of the association showed 
between sclera vessels and the antibiotic treatment in our results could be that the use of antibiotics 
in the case of E. coli infection is detrimental 41. Lipopolysaccharides (LPS), a component of the cell 
wall of gram-negative bacteria, are considered the primary virulence factor of coliform bacteria42, 
being responsible for most pathophysiological reactions in E. coli sustained diseases43, even 
endotoxemic shock. LPSs are released from the bacteria following cell death caused by 
antibiotics43,44 and the clinical signs are induced by LPSs as the consequence of inflammatory 
mediators being released43-45. In our study, the antibiotic had a negative influence on the feces, with 
more severe diarrhea for these clinical parameters in calves treated with antimicrobials. This result 
is in agreement with the literature. The negative correlation between antibiotics and dysbiosis was 
reported in literature, not only in calves. On the other hand, antibiotic treatment can influence the 
re-establishment of the normal microbiota and predisposes calves to relapses5-7. 
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The failure of treatment was influenced by eye/ear scores, cough, IgG and sTP concentrations. 
These results suggest that a lower concentration of IgG, sTP and the development of respiratory 
disease were correlated with the deterioration of the general conditions. A higher probability of 
sepsis linked to a lower concentration of IgG and sTP has already been seen in literature. The 
association is easily explained by the reduced effectiveness of the immune system in responding to 
the pathogens involved29,30. The respiratory symptoms of animals that had a deterioration of their 
general condition can be explained by the fact that bronchopneumonia therapy requires antibiotics 
and the influence of antibiotics on mortality rate in calves with bronchopneumonia is clearly 
documented46,47.  
In our study non-surviving calves had a high score for feces, attitude, eye/ear, cough, and nasal 
discharge. These findings suggest that non-surviving calves had developed multifocal infections 
(diarrhea and pneumonia) during the 28 days of observation. In humans the increase of mortality 
in diarrheic children with co-morbidities, such as pneumonia, is well described48. As our results 
show, Trefz et al.32 there is also a strong association between the concomitant presence of other 
diseases during NCD (in particular pneumonia) and an increased risk of mortality. In our study, 
no association between sTP and mortality was shown. This result is in disagreement with Boccardo 
et al.11 that underlined a higher fatality risk in calves with a low sTP concentration. The possible 
explanation for the lack of associations between mortality and sTP in our study can be explained 
by the use of hyperimmune plasma in calves with low sTP concentrations. The administration of 
plasma may have affected and modified mortality in this group of animals.  
Differences in bacterial membership and structure of the gut microbiota of calves treated with and 
without antibiotics during the first week of the study were observed. Our results showed that calves 
treated without antibiotics were able to re-establish their microbiota during the first week of 
hospitalization, while the calves treated with antibiotics re-established their microbiota after the 
second week of hospitalization. The impact of antimicrobial agents on calves has been 
demonstrated previously 49. Grønvold et al.49 showed a shift from the baseline (before treatment) 
followed by a gradual recovery towards the baseline over time in healthy calves treated with 
parenteral penicillin. These results are in accord with the microbiota change observed in calves 
treated with an antibiotics in our study.  
The antimicrobial treatment was associated with the decreased representation of members of the 
Phylum Actinobacteria and Family Lachnospiraceae in the fecal flora of calves at the second time 
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point. These bacteria were associated with ‘gut health’ in different species, including human 
beings50, horses51, dogs52 and calves 53. We speculate that treating calves without antimicrobials 
may have a beneficial effect on the gut microbiota of calves by favouring taxa associated with ‘gut 
health’.  
At 21 days of study the Families Bacteroidaceae, Porphyromonadaceae and Rikenellaceae were 
significantly higher in calves treated with antibiotics. These families were associated with health 
microbiota in calves53. These results suggest that no long-term effects of antibiotic treatment were 
present in the microbiota of calves. Re-establishment of a healthy microbiota in calves treated with 
antibiotics requires more time than calves treated without antimicrobials, but 3 weeks after NCD 
the quality of microbiota seems to be better. However, this difference is reduced compared to the 
difference observed at the second sampling and disappears in the last week of study. The quality 
of the microbiota does not seem to be different at the end of the observation period in animals 
treated with and without antimicrobials. 
In conclusion, our results strengthen the evidence of unnecessary antimicrobial treatments in NCD. 
Furthermore, the microbiota re-establishment seems to be faster in calves treated without 


















Table 1. Description of clinical score used for the evaluation of calves during the study period. 




2 Absent or chewing movements 
Temperature 
0 37.8 – 38.3 °C 
1 38.4 – 38.8°C 
2 38.9 – 39.4°C 
3 ≥ 39.5°C 
Attitude 
0 Normal behavior, alert, gets up when approached, interested in surroundings 
1 Depressed, must be stimulated to get up 
2 Gets up only with help 
3 Unable to stand, even with help 
Fececs 
0 Normal faeces 
1 Faeces softer than normal, but no diarrhea on tail 
2 Diarrhea but not profuse, wet tail 
3 Profuse watery diarrhea, wet tail, soiled pen, or any indication of blood or fibrin in faeces 
(but not normal faeces with a small amount of blood) 
Hydration 
0 Normal hydration, skin tent <2 s 
1 Moderate dehydration, eyeball slightly sunken (1-2mm), and skin tent >2 s but <4 s  
2 Obvious dehydration, sunken eyes (3-4mm), dry nose, skin tent >5 s  
3 Severe sunken eyes with an easily perceptible distance between the eyeball and the eyelid 
(≥5mm), cold ears, legs and oral cavity, dry mouth and nose, skin tent persists 
Scleral vessel 
0 Normal (<2), they do not reach the limbus 
1 Greater in number (<4), at least 1 reaches the limbus, colour is still pink, size is normal 
2 Greater in number (>4), at least 2 reach the limbus, colour is red, size is mildly increased 
3 Greater in number (>6), at least 3 reach the limbus, colour is purple, size is greatly 
increased 
Nasal discharge 
0 Normal serous discharge 
1 Small amount of unilateral cloudy discharge 
2 Bilateral, cloudy or excessive mucus discharge 
3 Copious bilateral mucopurulent discharge 
Eye/ear  
0 Normal 
1 Small amount of ocular discharge or ear flick or head shake 
2 Moderate amount of bilateral discharge or slight unilateral droop of ear 
3 Heavy ocular discharge, Head tilt or bilateral droop of ears  
Cough 
0 None 
1 Induced single cough 
2 Induced repeated coughs or occasional spontaneous cough 
3 Repeated spontaneous coughs 
Umbelicus 
0 Normal, pencil size, dry, and painless 
1 Bigger than normal, but dry and painless 
2 Bigger than normal, wet or painful 
3 Bigger than normal, with pus draining and evidence of pain (any presence of internal 
umbilical swelling ranks as a 3 and should be described as involving arteries/urachus or 
vein) 
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Table 2. Frequency and percentage of clinical parameters and average ± standard deviation of calf health scoring chart (CHSC), serum total 
protein (sTP; g/L) concentration and immunoglobulin G (IgG g/L) concentration in calves during the study period (28 days) splitted for groups. 
Group A1: animals affected by NCD with ATPI (sTP > 55 g/L), with antibiotic administration 
Group FA1: animals affected by NCD with ATPI (sTP > 55 g/L), without antibiotic administration 
Group A2: animals affected by NCD with ITPI (sTP < 55 g/L), with antibiotic administration 
Group FA2: animals affected by NCD with ITPI (sTP < 55 g/L), without antibiotic administration 
Score Suckle reflex Temperature Attitude Feces Hydration Scleral vessel Nasal discharge Eye/ear Cough Umbelicus CHSC sTP IgG 
Group A1  
0 221 (83%) 30 (11.8%) 213 (84%) 99 (39%) 220 (86.6%) 201 (79.1%) 249 (98%) 214 (84.2%) 242 (95.3%) 226 (89%) 3 (± 2) 50.6 (± 9.8) 12.2 (± 3.9) 
1 22 (8,7%) 116 (45.7%) 26 (10.2%) 84 (33.1%) 26 (10.2%) 42 (16.5%) 5 (2%) 36 (14.2%) 8 (3.1%) 27 (10.6%)    
2 21 (8,3%) 88 (34.6%) 7 (2.8%) 47 (18.5%) 6 (2.4%) 7 (2.8%) 0 4 (1.6%) 4 (1.6%) 1 (0.4%)    
3 / 20 (7.9%) 8 (3%) 24 (9.4%) 2 (0.8%) 4 (1.6%) 0 0 0 0    
Group FA1 
0 250 (91%) 25 (9.1%) 244 (88.7%) 113 (41.1%) 255 (92.7%) 248 (90.2%) 271 (98.5%) 246 (89.5%) 268 (97.5%) 263 (95.6%) 3.4 (± 2.4) 52.5 (± 8.9) 10.7 (± 3.3) 
1 18 (6.5%) 145 (52.7%) 27 (9.8%) 60 (21.8%) 13 (4.7%) 20 (7.3%) 4 (1.5%) 26 (9.5%) 6 (2.2%) 12 (4.4%)    
2 7 (2.5%) 83 (30.2%) 3 (1.1%) 63 (22.9%) 6 (2.2%) 7 (2.5%) 0 3 (1 %) 1 (0.4%) 0    
3 / 22 (8%) 1 (0.4%) 39 (14.2%) 1 (0.4%) 0 0 0 0 0    
Group A2 
0 157 (84%) 36 (19.3%) 150 (80.2%) 59 (31.6%) 162 (86.6%) 159 (85%) 177 (94.7%) 137 (73.3%) 170 (90.9%) 180 (96.3%) 3.8 (± 2.1) 45.5 (± 5.8) 8.6 (± 4.6) 
1 20 (10.7%) 62 (33.2%) 26 (13.9%) 56 (29.9%) 24 (12.8 %) 26 (13.9%) 7 (3.7%) 37 (19.8%) 13 (7%) 7 (3.7%)    
2 10 (5.3%) 67 (35.8%) 8 (4.3%) 47 (25.2%) 0 2 (1.1%) 3 (1.6%) 8 (4.3%) 4 (2.1%) 0    
3 / 22 (11.8%) 3 (1.6%) 25 (13.4%)  1 (0.6%) 0 0 5 (2.7%) 0 0    
Group FA2 
0 146 (90.7%) 26 (16.1%) 136 (84.5%) 88 (54.7%) 141 (87.6%) 122 (75.8%) 151 (93.8%) 147 (91.3%) 144 (89.4%) 150 (93.2%) 3.3 (± 2.7) 45.9 (± 5.2) 8.2 (± 4.2) 
1 6 (3.7%) 61 (37.9%) 10 (6.2%) 36 (22.4%) 14 (8.7%) 33 (20.5%) 6 (3.7%)  6 (3.7%) 16 (9.9%) 8 (5%)    
2 9 (5.6%) 65 (40.4%) 7 (4.3%) 21 (13%) 5 (3.1%) 5 (3.1%) 4 (2.5%) 5 (3.1%) 1 (0.6%) 1 (0.6%)    
3 / 9 (5.6%) 8 (5%) 16 (9.9&%) 0 1 (0.6%) 0 3 (1.9%) 0 2 (1.2%)    
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Table 3. Relative abundance of the main phyla, class, order and family identified in faces of calve 
treat with and without antibiotic treatment during the period study.  
Taxa Time points 
Calves treat without antibiotic 
(groups FA1 and FA2) 
Calves treat with antibiotic 
(groups A1 and A2) 
p value 
Phyla 
Firmicutes 1 0.5061 0.5776 0.3525 
 2 0.5197 0.5651 0.5705 
 3 0.6352 0.6014 0.5855 
 4 0.5846 0.6239 0.5398 
 5 0.6004 0.6253 0.7667 
Bacteroidetes 1 0.0445 0.0974 0.0590 
 2 0.1668 0.1872 0.7697 
 3 0.1772 0.2340 0.3145 
 4 0.1963 0.2582 0.2641 
 5 0.2034 0.2978 0.1496 
Proteobacteria 1 0.3126 0.1777 0.0738 
 2 0.1059 0.1186 0.8114 
 3 0.0488 0.0192 0.1087 
 4 0.1187 0.0286 0.1910 
 5 0.0290 0.0051 0.2029 
Actinobacteria 1 0.0276 0.0443 0.4788 
 2 0.1379 0.0537 0.0457* 
 3 0.0966 0.1148 0.6954 
 4 0.0640 0.0488 0.4205 
 5 0.1043 0.0626 0.3685 
Class 
Bacilli 1 0.3060 0.3198 0.8634 
 2 0.1364 0.1824 0.5459 
 3 0.0504 0.0631 0.7227 
 4 0.0707 0.0379 0.3662 
 5 0.0302 0.0215 0.6622 
Gammaproteobacteria 1 0.2942 0.1646 0.0897 
 2 0.0995 0.1114 0.8241 
 3 0.0418 0.0160 0.1430 
 4 0.1141 0.0194 0.1722 
 5 0.0243 0.0022 0.1849 
Clostridia 1 0.1698 0.2130 0.4530 
 2 0.2811 0.2315 0.4428 
 3 0.3976 0.3774 0.8101 
 4 0.3351 0.4061 0.3433 
 5 0.4382 0.4294 0.9241 
Bacteroidia 1 0.0439 0.0968 0.0600 
 2 0.1659 0.1869 0.7634 
 3 0.1771 0.2336 0.3170 
 4 0.1963 0.2581 0.2644 
 5 0.2034 0.2977 0.1498 
Fusobacteriia 1 0.0352 0.0982 0.1286 
 2 0.0566 0.0566 0.9999 
 3 0.0255 0.0025 0.3570 
 4 0.0301 0.0307 0.9870 
 5 0.0508 0.0003 0.3520 
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Order 
Lactobacillales 1 0.3044 0.3183 0.8614 
 2 0.1360 0.1805 0.5571 
 3 0.0500 0.0627 0.7214 
 4 0.0687 0.0377 0.3942 
 5 0.0293 0.0211 0.6807 
Enterobacteriales 1 0.2813 0.1385 0.0600 
 2 0.0873 0.0954 0.8756 
 3 0.0337 0.0122 0.1911 
 4 0.1117 0.0182 0.1734 
 5 0.0209 0.0012 0.2131 
Clostridiales 1 0.1698 0.2130 0.4530 
 2 0.2811 0.2315 0.4428 
 3 0.3976 0.3774 0.8101 
 4 0.3351 0.4061 0.3433 
 5 0.4382 0.4294 0.9241 
Bacteroidales 1 0.0439 0.0968 0.0600 
 2 0.1659 0.1869 0.7634 
 3 0.1771 0.2336 0.3170 
 4 0.1963 0.2581 0.2644 
 5 0.2034 0.2977 0.1498 
Fusobacteriales 1 0.0352 0.0982 0.1286 
 2 0.0566 0.0566 0.9999 
 3 0.0255 0.0025 0.3570 
 4 0.0301 0.0307 0.9870 
 5 0.0508 0.0003 0.3520 
Family 
Enterobacteriaceae 1 0.2813 0.1385 0.0600 
 2 0.0873 0.0954 0.8756 
 3 0.0337 0.0122 0.1911 
 4 0.1117 0.0182 0.1734 
 5 0.0209 0.0012 0.2131 
Lactobacillaceae 1 0.2366 0.2495 0.8760 
 2 0.0657 0.1510 0.2086 
 3 0.0221 0.0202 0.8912 
 4 0.0466 0.0143 0.2516 
 5 0.0262 0.0158 0.5980 
Lachnospiraceae 1 0.1106 0.0822 0.4948 
 2 0.1141 0.0359 0.0421* 
 3 0.1573 0.0973 0.3062 
 4 0.1191 0.1047 0.6594 
 5 0.1228 0.0918 0.3726 
Streptococcaceae 1 0.0441 0.0252 0.27188 
 2 0.0202 0.0042 0.2030 
 3 0.0073 0.0056 0.7658 
 4 0.0135 0.0111 0.8059 
 5 0.0014 0.0036 0.1072 
Ruminococcaceae 1 0.1028 0.1012 0.9203 
 2 0.1271 0.1762 0.3505 
 3 0.1903 0.2562 0.3684 
 4 0.2067 0.2845 0.2473 




Figure 1. Graphic representation of mortality rate and failure of treatment in the different 




Figure 2. Curves of average alpha diversity indexes. In the y-axis is reported the values and in x-
axis is reported the time points. Group 0 represented the calves treated without antibiotics, while 
group 1 represented calves treated with antibiotics. A significant increase of richness at the 
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Neonatal calf diarrhea (NCD) is the most critical disease in preweaning calves and causes 
great	economic losses. We evaluated the long-term effects of NCD on reproductive and production 
outcomes during the first lactation. We also analyzed the effect of the severity of the largest 
clinicopathologic abnormalities observed during NCD on subsequent first production and 
reproductive performance. Clinical and laboratory findings were reviewed in 88 Holstein Friesian 
diarrheic calves over a 4-year period. Calves were treated according to a fluid therapy protocol and 
then discharged from the hospital in a healthy state. For each animal, days in milk (DIM), 305-day 
milk yield, milk fat and protein production, and age of first calving (AFC) were recorded. For the 
control group, we examined non-hospitalized heifers (n=85) of the same age and from the same 
herd without a clinical history of NCD. General linear model analysis showed that there were no 
significant differences between the two groups concerning DIM (P=0.740), 305-d milk yield 
(P=0.883), fat (P=0.660) and protein (P=0.582) production, and AFC (P=0.879). No effect of the 
severity of NCD on the first performance was found. These findings suggest that treated NCD had 
no effect on AFC and first lactation production. This would ensure suitable reproductive and 
production standards during the first lactation even in calves that have had severe NCD. 
 
Key words  
dairy cattle; neonatal calf diarrhea; production performance; reproductive performance 
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Introduction  
Pathological events occurring during the prepubertal period may have long-term effects on the 
reproductive and production performance of dairy heifers that survive the clinical episode (Chuck 
et al., 2018). In fact, several studies suggest a correlation between growth rate, mammary gland 
development and the onset of sexual maturity (Van Amburgh et al., 1998; Garcia et al., 2002; Silva 
et al., 2002). Early identification of pathological events occurring during the first stage of life is 
important to prevent this negative influence both on the average daily gain (ADG), which can raise 
the age at first calving (AFC), and on the reduction in milk yield at first lactation (Van der Fels-
Klerx et al., 2002; Aghakeshmiri et al., 2017). 
Neonatal calf diarrhea (NCD) is the most common cause of morbidity and mortality in pre-weaned 
dairy calves and causes great economic losses worldwide, due to the mortality, treatment costs and 
decreased heifer replacement rates (Torsein et al., 2011; USDA, 2012). The importance of the long-
term effects of NCD is still an open issue. Episodes of diarrhea can significantly decrease calves' 
ADG, especially during the first six months of life (Donovan et al., 1998). Waltner-Toews et al. 
(1986) reported that heifers treated for diarrhea in the first 90 d of life were 2.9 times more likely 
to calve after 900 d of age than other heifers. In other studies, heifers with a history of diarrhea 
showed a higher AFC, compared to calves without a history of this disease (Rossini, 2004; 
Aghakeshmiri et al., 2017). Furthermore, an association between diarrhea and decreased milk 
production during the first lactation has been found (Svensson and Hultgren, 2008). Conversely, 
other studies did not find any difference between the production and reproductive performance 
and diarrhea occurrence (Britney et al., 1984; Warnick et al., 1995; Heinrichs and Heinrichs, 2011; 
Chuck et al., 2018).  
Most of the studies mentioned so far in this introduction were performed on heifers with a history 
of mild diarrhea, non-specific enteritis during their first 3-4 months of life or owner-
diagnosed/treated enteritis. Moreover, none of these studies reported the specific therapeutic 
protocols used to treat diarrhea or considered the severity of clinical and laboratory findings. To 
address this knowledge gap, the present study evaluated the first AFC, the length of the first 
lactation (days in milk; DIM), 305-d equivalent milk yield, milk fat and protein content in the first 
lactation of heifers that survived a mild to severe episode of NCD which was treated at a veterinary 





Materials and methods  
Case selection  
A retrospective case-control study was performed employing the clinical records of client-owned 
dairy calves admitted to the Veterinary Teaching Hospital of the University of Milan with a clinical 
diagnosis of NCD on initial examination. Clinical diagnosis of NCD was based on the presence of 
watery feces at admission in calves aged between 1-28 days of life. The case group was 
retrospectively recruited between March 2010 and December 2014. Within this sample, we 
considered only diarrheic Holstein Friesian females that had been discharged and who had 
successfully completed the first lactation. Other concurrent diseases at the time of hospitalization 
represented an exclusion criterion. We also included only heifers belonging to dairy farms located 
in Lombardy (Italy), that had been regularly checked by our bovine ambulatory clinic, had referred 
at least 5 NCD cases and had given their written informed consent to the use of clinical, production 
and reproductive data. Furthermore, to reduce the risk of uncontrolled pathological events that 
could have altered the evaluation of the production outcomes, we used only data from farms with 
a high level of registration and maintaining of the individual animal events diagnosed by the herd 
veterinarian. 
A dataset (Provet Cloud, Finnish Net Solutions Ltd, Tekniikantie, Finland) of 432 diarrheic calves 
from 61 dairy herds was reviewed. The calves that survived the clinical episode of NCD were 322. 
Of these, 273 calves were female Holstein Friesian without other concurrent diseases. Nine dairy 
herds, with a demonstrated ability to record individual animal event details, consent to the use of 
clinical and productive data of their animals for a total of 162 calves. Of these, 28 calves 
experienced some form of sickness during the pre- or postweaning period, 12 died during the same 
period. 34 heifers were excluded from the data set because of complications such as dystocia, 
lameness, metabolic disturbances, culling, etc. during the first lactation. Therefore, in accordance 
with the selection criteria, 88 female diarrheic Holstein calves belonging to nine commercial dairy 
farms without any pathological events recorded after discharge from the Veterinary Teaching 
Hospital, were included in this study as a case group. 
For the control group, we selected animals from the same herd that had no clinical history of NCD 
and without any pathological events recorded until the end of the first lactation. For each 
hospitalized diarrheic calf, a non-hospitalized animal of the same age (± 30 days) was included in 
the control group. A total of 85 controls were selected and linked to the 88 cases. The difference 
between sampling numbers was due to the fact that on one farm, in a given period, most of the 
new-born calves had NCD and it was therefore not possible to obtain an adequate number of 
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negative controls that would respond to age inclusion requirements. For this reason, three controls 
were linked to two clinical cases. 
 
Clinical procedures  
Recorded information from each medical record included detailed history referring to the onset 
and duration of clinical symptoms before admission (inappetence, lethargy, sunken eyes or watery 
feces), body weight, clinical examination on arrival and during daily checks, laboratory findings, 
treatment, and outcome. 
On admission, diarrheic calves were weighed (Omega Twin 3, Omega Bilance S.r.l, Varese, Italy), 
submitted to a complete clinical examination and laboratory tests. Clinical scores and 
categorization into subgroups were used for the analysis of age, vigor, dehydration, suckle reflex 
and rectal temperature (see Table 1), based on previous retrospective investigations (Fecteau et al., 
2009; Boccardo et al., 2017).  
A blood sample was collected in a 9-mL tube without anticoagulant from the jugular vein and used 
to determine serum total proteins (sTP). Samples were allowed to clot and then centrifuged at 20 
°C for 10 min at 900 g. The titre of sTP was determined with a hand refractometer and categorized 
into 2 subgroups (sTP ≤ 55 g/L, sTP > 55 g/L). One further blood sample for venous blood-gas 
analysis was also anaerobically collected from the jugular vein into a disposable heparinized 2.5 mL 
syringe, blood pH, bicarbonate (HCO3), partial pressure of carbon dioxide (pCO2), base excess 
(BE), blood sodium (Na⁺), chlorine (Cl⁻), potassium (K⁺) and anion gap (AG) were immediately 
determined using a blood gas analyzer (AVL Opti CCA, Diamond Diagnostic, Holliston, USA). 
After blood-gas analysis, two capillary tubes were filled with the remaining heparinized blood, 
centrifuged for 10 min in a microhematocrit centrifuge (NF 048, Nüve, Ankara, Turkey), and used 
for microhematocrit determination (Ht). Each parameter was categorized with a 3-point scale using 
the reference range as the discriminating factor (low values, normal values, high values), except for 
pH, where the choice of subgroups was based on the severity of the results (reference range: pH 
7.35–7.45; moderate acidemia: pH 7.20–7.34; severe acidemia: pH ≤ 7.19).  
All case group calves had at least one clinical sign of systemic illness. Table 2 reports the data 
retrieved from the clinical and laboratory records of the affected calves and the descriptive analyses. 
 
Treatment and housing 
Therapy of the 88 calves in the case group calves was performed according to a standard protocol 
(Boccardo et al., 2017). Diarrheic calves with a strong suckling reflex, vigor 1 and 2, dehydration 1 
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and 2 and B.E. up to -8 mmol/L received on admission 1 L of a homemade oral rehydration solution 
(ORS) containing 4 g sodium chloride, 20 g dextrose, 3 g potassium bicarbonate, and 3 g sodium 
propionate. One L of ORS was also offered three times within the first 24 h between milk feeds. 
Calves with vigor of 3-5, or dehydration of 3-4 or B.E. < -8 mmol/L, received 5 L of isotonic saline 
solution spiked with an amount of commercially available solution of 8.4 % sodium bicarbonate at 
constant drip infusion (40 mL/kg/h IV). The required amount of sodium bicarbonate was adapted 
for each calf and calculated as follows (Lorenz and Vogt, 2006): bicarbonate requirements (g) = 
body weight (kg) x B.E. (mmol/L) x 0.6 (L/kg) x 0.084 (g/mmol). After this solution, calves with a 
dehydration of 4 received an additional 5 L bag of isotonic saline solution at a slow infusion rate 
(10 mL/kg/h IV). Infusion solutions were administered through an IV catheter (Introcan Safety 
22G x 25 mm, BBraun, Melsungen, Germany) placed in an auricular vein. Calves with a history of 
malnutrition or lack of milk intake for more than 12 h, received 400 mL of a 50% glucose solution 
added to the saline solution. Hypothermic calves were placed under an infrared lamp. On the day 
of hospitalization, flunixin meglumine (Alivios, Fatro, Ozzano dell'Emilia, Italy) at a dose of 2.2 
mg/kg IV, vitamin E and selenium (Selevit, Fatro, Ozzano dell'Emilia, Italy) and group B vitamins 
(Dodicile, Fatro, Ozzano dell'Emilia, Italy) were administered parenterally. Finally, calves with the 
presence of at least one of the systemic signs of illness (e.g. 24 h of inappetence, dehydration score 
= 2, lethargy, pyrexia or bloody diarrhea) or sTP less than 55 g/L, received amoxicillin and 
clavulanic acid (Synulox, Zoetis Italia, Roma, Italy) subcutaneously at a dose of	10	+ 2.5 mg/Kg for 
5 days. Calves with deterioration (or failed improvement) of hydration, vigor and suckle reflex 
scores, 24 h after therapy	or deterioration after an initial improvement, were subjected to an 
additional blood gas analysis. These unresponsive calves were then treated with further IV fluid 
therapy based on their current acid–base and dehydration status. After the reappearance of the 
suckle reflex, 2 L of milk replacer was offered three times a day.  
The 88 NCD calves were assigned to standard treatments based on clinical and acid-base status 
(see Table 3). Glucose was added to infusion fluids in 70 cases. The infrared lamp was used in 32 
cases. Antimicrobial therapy was performed in all cases.  
During hospitalization, calves were housed in individual calf brick pens (1.8 m × 1.2 m) in an 
indoor 30- place stall with a controlled temperature of 18 °C. The pens were bedded with straw 
and cleaned every day. Freshwater, hay and calf starter were offered ad libitum. Uniform treatment 
procedures were ensured by daily patient rounds performed by at least one experienced clinician. 
Calves were monitored twice daily with complete clinical examinations. Surviving calves were 
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discharged from the hospital in a healthy state (normal hydration and vigor scores, good appetite 
and normal consistency of the feces for at least two days) on average after 7.4 ± 2.8 days. 
 
Production data 
Production data and reproductive performance of all animals included in the study (case group n 
= 88 and control group n = 85) recorded by ARAL (Associazione Regionale Allevatori della 
Lombardia), were extrapolated from the cowfile of each farm using Dairy Comp 305™ software 
(Valley Agriculture Software, Tulare, USA). For the analysis of reproductive data, we considered 
AFC (days). For the analysis of lactation performance, milk yield (kg) and milk composition (fat 
and proteins in kg) data were collected for both diarrheic cases and controls, through the monthly 
dairy herd index control performed by ARAL. The analysis was assessed using normalized 305-d 
first-lactation milk yield, based on the actual lactation days of each animal and considering the 
relative DIM of each cow. 
 
Statistical analysis 
For the statistical analysis, the collected data was organized and analyzed using IBM SPSS Statistics 
version 25.0 for Macintosh (IBM Corp, Armonk, USA). Descriptive analyses of clinical and 
laboratory data consisted of the calculation of the mean, standard deviation (SD), and minimum 
and maximum values. The long-term effects of NCD on the first lactation were analyzed using 
DIM, 305-d milk yield, milk fat, and milk proteins and AFC. The analysis for these outcome 
dependent variables, corrected for production data, between cases and controls was applied with 
the generalized linear model (GLM), using an identity link function and an inverse Gaussian 
distribution, since values were not normally distributed, tested by the Shapiro-Wilk test. Statistical 
significance was accepted for P values < 0.05. After categorizing the cases according to the severity 
of clinical and laboratory findings, the analysis of variance between cases and linked controls was 
performed using the same GLM. 
Results 
Univariate analysis showed no differences between cases and controls for DIM (case group: 320.9 
± 89.6 d; controls: 297.5 ± 120.3 d; P=0.740), 305-d milk yield (case group: 10867.4 ± 1556.6 kg; 
controls: 10624.5 ± 1431.9 kg; P=0.883), milk fat (case group: 370.6 ± 143.7 kg; controls: 371.2 ± 
102.8 kg; P=0.660), milk protein (case group: 334.2 ± 111.4 kg; controls: 326.2 ± 90.4 kg; P=0.582) 
and AFC (case group: 916.4 ± 128.3 d; controls: 887.0 ± 128.0 d; P=0.879). Tables 4 and 5 report 
the statistical analysis of the association between the severity of clinical and laboratory findings and 
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reproductive and production data. No statistical differences were found in any of the parameters 
considered between case heifers and controls. 
Discussion  
The present study was designed to determine the long-term effects of NCD in dairy heifers 
discharged from a veterinary teaching hospital after being subjected to a standard therapeutic 
protocol. 
The results of our investigation show that clinical episodes of NCD and the severity of NCD- 
associated clinicopathologic abnormalities do not affect first production and AFC. Previous studies 
have demonstrated that juvenile diarrhea may have production long-term consequences for dairy 
heifers, although other studies have shown no effect on the first lactation (Warnick et al., 1995; 
Svensson and Hultgren, 2008; Aghakeshmiri et al., 2017; Chuck et al., 2018). Most studies on the 
long-term effects of diarrhea were performed using clinical data provided by farmers or calf 
caretakers. Only one study (Aghakeshmiri et al., 2017) used clinical information provided by the 
veterinarian. The evaluation of owner-diagnosed/treated calfhood diseases represents the most 
significant limitation of these studies (Chuck et al., 2018). Although some farmers are specifically 
trained to recognize and treat the major diseases of calves, the use of antimicrobials or crystalloid 
solutions during the preweaning period by calf caretakers, in our opinion, should be carried out 
with caution. This is because farmers’ decision-making is usually influenced by many different 
factors (Vaarst and Sørensen, 2009; Derks et al., 2013; Bronner et al., 2014), and generally they 
lack the medical knowledge and skills thus leading to malpractice or iatrogenic diseases (Sala et al., 
2019). 
In our study, the clinical diagnosis of NCD was related to the presence of watery feces at admission 
in a referral veterinary center after a full clinical examination, carried out by an experienced 
veterinarian. Strict selection criteria were therefore applied to rule out other conditions that could 
have influenced the parameters under study. Furthermore, the therapy administered to the affected 
calves was performed according to a standard protocol, and both clinical and laboratory data were 
included in the generalized linear model employed. 
The findings of the current study do not support previous studies that suggest that diarrhea has 
negative effects on the first-lactation production in Holsteins. In calves included in the study by 
Svensson and Hultgren (2008), the occurrence of diarrhea was associated with episodes of 
respiratory disease. Similarly, Heinrichs and Heinrichs, (2011) evaluated cough and diarrhea 
together but without differentiating between respiratory and enteric diseases. The bovine 
respiratory disease complex is the most common pathological cause to affect ADG during the 
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growth period (Van der Fels-Klerx et al., 2002; Thompson et al., 2006). Data obtained in calves 
and in animal models show that the effects of lung lesions may persist for a long time, reducing 
pulmonary functions and growth rates during the prepubertal period (Domachowske et al., 2004), 
however intestinal mucosa seems to have a major ability to react to injuries (Rose II et al., 2012). 
Because of the strict selection criteria employed for the definition of clinical disease, the absence 
of long-term effects in the present study may be explained, at least in part, by the fact that 
respiratory diseases were ruled out as a possible factor associated with NCD. Other studies have 
shown that diarrhea has a negative impact on AFC, due to the profound effects on growth rate 
during the rearing period (Waltner- Toews et al., 1986; Aghakeshmiri et al., 2017). During NCD 
episodes, the clinical status of healthy calves can change suddenly, leading to a rapid and severe 
impairment of mental status, degree of dehydration, the strength of the suckle reflex, ability to 
stand, and interest in feeding. Therefore, NCD may lead to reduced growth rates due to prolonged 
malnutrition, cachexia and longer recovery times. This is especially true when there is a lack of 
adequate measures to minimize the disease impact, for example in calves receiving oral rehydration 
solutions alone but no milk, or in cases treated only with antimicrobial therapy (Naciri et al., 1999; 
Wattiaux, 2005; Berge et al., 2009). Re-establishing tissue perfusion, in combination with the focus 
on milk feeding and supportive care, creates the preconditions for a favorable recovery. This thus 
reduces the importance of NCD occurrence during the growth period on the subsequent first 
calving.  
Besides clinical episodes of NCD, the severity of clinical presentation, sTP, acid-base, and 
electrolyte imbalance in surviving calves, do not affect the first production and reproductive 
performance. In terms of the severity of NCD, the lack of correlation between diarrhea and first 
production and reproductive performance found in previous studies could be explained by the fact 
that the affected calves were less likely to become part of the milking herd due to a higher mortality 
and culling rate (Warnick et al., 1995). Clearly, if the disease progresses without accurate therapy, 
life-threatening conditions such as extreme hypothermia, hypoglycemia, prostration, and shock 
become evident. In affected calves, profound acidemia, hypoproteinemia, lack of suckle reflex, 
increase in serum urea, K⁺, and Cl⁻ concentrations, hypoglycemia, and failure of respiratory 
compensation have been significantly associated with mortality risks (Fayet and Overwater, 1978; 
Seifi et al., 2006; Boccardo et al., 2017; Trefz et al., 2017; Tsukano et al., 2018). Although some of 
these conditions represent an important factor that reduces the efficiency of the NCD therapeutic 
protocols, diarrheic calves are still able to respond positively to therapy as long as there are no 
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conditions such as septicemia, central nervous system diseases, abdominal emergencies or arthritis 
(Trefz et al., 2017; Bonelli et al., 2018). 
In non-complicated episodes, a thorough therapeutic protocol can prevent the systemic effects of 
diarrhea, which include loss of extracellular fluid and electrolytes, and the malabsorption of 
carbohydrates with their subsequent fermentation in the intestine. Previous studies have shown 
that the clinical presentation of diarrheic calves is related to the increase in blood D-lactate levels 
(Lorenz, 2004). Calves with high D-lactate concentrations did not need additional specific therapy, 
as D-lactate concentrations regularly fell following the correction of acidosis and restitution of body 
fluid volume (Müller et al., 2012). In diarrheic calves, hyperkalemia causes muscle weakness and 
cardiac arrhythmias. Trefz et al. (2015) found that alkalinization and dehydration correction were 
the best treatments to enhance the renal elimination of K⁺ ions. Similarly, suckle reflex and 
respiratory compensation are depressed by a reduced cerebrospinal fluid bicarbonate 
concentration and severe dehydration which can be managed with an alkalinizing crystalloid fluid 
therapy (Abeysekara et al., 2007; Tsukano et al., 2018). Furthermore, a reasoned approach to 
antibiotic use in calves with systemic signs of illness, the modulation of the inflammatory response 
with nonsteroidal anti-inflammatory drugs, and the support of calves during the critical phases can 
reduce the risk of neonatal septicemia during NCD episodes (Fecteau et al., 2009).  
The role of sTP is critical. The serum TP concentration is commonly used for the evaluation of the 
transfer of passive immunity. After colostrum ingestion, in fact, the concentration of sTP increases 
by about 60% and may be correlated with the passive transfer of immunity until up to 9 d of age 
(Boccardo et al., 2016; Wilm et al., 2018). Previous studies have postulated the role of colostrum 
volume ingested and level of passive immunity in future production performance due to an 
enhanced culling and mortality rate or due to an unspecified growth-promoting activity of the 
colostrum (DeNise et al., 1989; Faber et al., 2005). In contrast with these previous studies, our 
results show no differences in production and reproductive indices in diarrheic calves with a sTP 
cut-off value of 55 g/L. A possible explanation is the absence of long-term effects of the immune 
system in surviving calves, due to the normal development of the cellular and humoral immunities 
which increase gradually during the first month of life and mature approximately at six months 
after birth (Chase et al., 2008). Furthermore, despite its frequent use in passive transfer evaluation, 
the sTP concentration in critically ill calves is still an open issue. Especially in diarrheic calves >1 
week of age, the causes of hypoproteinemia that are directly correlated with NCD (e.g., protein-
losing enteritis, gastro-intestinal blood loss, anorexia) cannot be ruled out (Boccardo et al., 2017). 
Conversely, in diarrheic calves, serum refractance can become worse because of dehydration or an 
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increase in blood inflammatory proteins (Buczinski et al., 2018). These factors increase the risk of 
misclassification concerning the passive transfer of immunity in sick calves, thus reducing the 
accuracy of our correlation between sTP and subsequent first productions in calves with NCD.  
One of the results that emerge from this study is that NCD does not affect first production and 
reproductive performance in heifers treated with an efficient fluid and supportive therapeutic 
protocol. Prompt therapeutic intervention may be necessary to reduce NCD-related 
clinicopathologic abnormalities, which can result in potentially reduced growth rates during the 
rearing period. In addition, an efficient therapeutic protocol seems to play an important role in 
subsequent production and reproductive performance also in calves with severe NCD.  
Our study had several limitations. It was based on calves in a hospital setting with naturally 
occurring NCD, and variability existed among the calves in terms of severity and chronicity of the 
disease. Nonetheless, several protocols for treating NCD in field practice have been suggested 
(Trefz et al., 2012), so that similar results are expected also in field conditions. The relatively small 
number of calves studied, can render some of the statistical comparisons underpowered, increasing 
the likelihood of type II error. Additional studies including a higher number of calves are indicated.  
Conclusion 
The current study aimed to determine the effects of NCD on the first production and reproductive 
performance in hospitalized animals treated with a standard therapeutic protocol. The results of 
this study indicate that uncomplicated NCD episodes in affected calves treated with an efficient 
therapeutic protocol do not affect AFC, 305-d equivalent milk yield, DIM, milk-fat and milk-
protein production during the first lactation. First production and reproductive performance were 
also not affected by severe clinicopathologic abnormalities. We believe that the findings reported 
here shed new light on early-life pathological events associated with first-lactation performance in 
dairy cattle. Further research could be performed to assess the future impact of NCD in a larger 
number of calves undergoing closely monitored therapeutic protocols in field conditions. 
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Table 1. Description of clinical classes used for the evaluation of the age, vigor, dehydration, suckle 
reflex and temperature in calves with neonatal calf diarrhea. 
Classes Clinical findings 
Age (Fecteau et al., 2009) 
1 ≤ 7 days 
2 > 7 days 
  
Vigor (Boccardo et al., 2017) 
1 Standing securely without assistance, curious, alert 
2 Standing up after encouragement, weak, ‘sad calf’ 
3 Sternal recumbency, standing after lifting, ‘drunken gait’, insecure posture 
4 Permanent sternal/costal recumbency 
5 Lateral recumbency, sometimes comatose 
  
Dehydration (Boccardo et al., 2017) 
1 Normal hydration, upper eyelid skin tent <2 s 
2 Moderate dehydration, eyeball slightly sunken (1–2 mm), and upper eyelid skin 
tent >2 s but <4 s (estimated loss of body mass 3–5%) 
3 Obvious dehydration, sunken eyes (3–4 mm), dry nose, upper eyelid skin tent >5 
s (estimated loss of body mass 6–8%) 
4 Severe sunken eyes with an easily perceptible distance between the eyeball and 
the eyelid (³5 mm), cold ears, legs and oral cavity, dry mouth and nose, upper 
eyelid skin tent persists (estimated loss of body mass ³9%) 
  
Suckle reflex (Boccardo et al., 2017) 
1 Strong 
2 Weak 
3 Absent or chewing movements 
  
Rectal temperature (°C) 
1 < 38.5 (hypothermia) 
2 38.5 – 39.5 
3 > 39.5 (fever) 
Table 2. Descriptive analysis of the clinical and laboratory data for diarrheic calves at admission. 
Variables Mean ± SD Min Max 
Age (d) 8.5 ± 4.9 1 25 
Vigor 3.2 ± 0.9 2 5 
Dehydration 2.8 ± 0.7 2 4 
Suckling reflex 1.8 ± 0.7 1 3 
Rectal temperature (°C) 38.5 ± 1.4 33.3 40.9 
Serum total protein (g/L; reference range 55 to 75) 58.9 ± 10.9 35 89 
pH (reference range; 7.35-7.45)  7.1 ± 0.1 6.89 7.44 
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Partial pressure of carbon dioxide (mmHg; reference range 35 to 
50) 
41.2 ± 9.7 
18 66 
Blood bicarbonate (mmol/L; reference range 10 to 20 mmol/L) 15.2 ± 6.3 5 32.2 








Blood potassium (mmol/L; reference range 3.9 to 5.8) 5.7 ± 1.6 2.4 9.9 
Blood chloride (mmol/L; reference range 97-110) 102.7 ± 8.7 84 136 
Anion gap (mmol/L; reference range 8 to 16) 17.5 ± 5.6 1.5 34.6 
Microhematocrit (%; reference range 18 to 30) 34.7 ± 7.5 18 59 
 
Table 3. Results obtained in 88 calves after a standard treatment protocol with oral rehydration 
solution (ORS) or isotonic saline with 8.4% sodium bicarbonate (NaHCO3) based on clinical and 
acid–base status. 
Therapeutic protocol ORS (4 
calves)a 
5 L isotonic saline + 
8.4% NaHCO3 (50 
calves)b 
10 L isotonic saline 
+ 8.4% NaHCO3 (34 
calves)c 
No clinical improvement 12-24h after therapy - 19 - 
Deterioration of the general conditions after a 
primary improvement 1 5 9 
Therapeutic protocol for the unresponsive calves 
further subjected to fluid and bicarbonate therapy 
according to their clinical and acid-base status 
 1a 10b 5c 9b 4c 
 a Diarrheic calves with strong suckle reflex, vigor 1 and 2, dehydration 1 and 2, and base excess 
up to 8 mmol/L received on admission 1 L of ORS containing 4 g sodium chloride, 20 g dextrose, 
3 g potassium bicarbonate and 3 g sodium propionate. One liter of ORS was additionally 
administered three times between milk feedings during the first 24 h after admission.  
b Calves with vigor of 3-5, or dehydration of 3-4 or base excess < 8 mmol/L received a constant 
drip infusion consisting of 5 L of isotonic saline spiked with 8.4% NaHCO3 at constant drip 
infusion (40 mL/kg/h). 
c Calves with dehydration score of 4 received an additional 5 L bag of isotonic saline at slow 








Table 4. Results of generalized linear model for association between clinical classes and variables 
of interest (DIM, 305-day milk yield, milk fat and protein production, and AFC) in 88 surviving 
calves with neonatal calf diarrhea treated with a standard veterinary hospital protocol and 85 non-
affected controls. 
Classes n. DIM ± SD (d) P 
305-d milk yield ± 
SD (kg) P 
Milk fat ± SD 
(kg) P 
Milk protein ± 
SD (kg) P AFC ± SD (d) P 
Age (d) 
1 Cases 38 285.8 ± 111.1 0.408 10225.0 ± 1695.0 0.620 328.1 ± 149.9 0.311 303.1 ± 131.6 0.463 935.3 ± 146.4 0.927 Controls 35 316.8 ± 97.9 9976.3 ± 1452.1 380.9 ± 137.9 339.8 ± 112.4 933.6 ± 139.4 
2 Cases 50 331.1 ± 122.6 0.690 10738.8 ± 1481.2 0.482 395.8 ± 159.4 0.981 352.2 ± 131.7 0.992 887.6 ± 132.4 0.697 Controls 50 314.7 ± 123.0 11014.7 ± 1834.1 394.5 ± 157.5 351.8 ± 133.8 881.9 ± 147.1 
Vigor1 
2 Cases 26 261.5 ± 109.6 0.602 10407.4 ± 1915.0 0.597 308.4 ± 151.6 0.381 281.4 ± 130.5 0.471 903.0 ± 109.9 0.539 Controls 25 295.0 ± 136.1 10067.0 ± 1612.6 380.0 ± 177.4 335.3 ± 152.6 912.9 ± 123.2 
3 Cases 31 338.4 ± 141.3 0.815 10330.6 ± 1424.2 0.530 403.0 ± 167.7 0.782 357.3 ± 143.7 0.720 933.0 ± 180.4 0.502 Controls 30 327.1 ± 123.9 10610.1 ± 2239.3 386.7 ± 156.9 338.4 ± 130.8 914.6 ± 170.2 
4 Cases 23 317.6 ± 92.5 0.866 10574.2 ± 1253.8 0.304 358.1 ± 138.0 0.287 335.1 ± 116.7 0.413 885.0 ± 120.0 0.607 Controls 22 322.4 ± 80.7 10952.6 ± 1234.8 402.5 ± 125.5 363.1 ± 97.6 863.8 ± 148.7 
5 Cases 8 352.4 ± 82.6 0.278 11430.1 ± 1861.4 0.655 392.6 ± 88.3 0.381 346.0 ± 76.7 0.861 895.5 ± 102.9 0.223 Controls 8 318.5 ± 59.9 11120.7 ± 990.7 388.1 ± 92.3 370.6 ± 74.4 938.1 ± 91.3 
Dehydration1 
2 Cases 32 298.3 ± 116.3 0.527 10447.3 ± 1769.9 0.792 351.8 ± 144.9 0.405 314.2 ± 125.4 0.501 890.4 ± 132.1 0.875 Controls 32 327.2 ± 108.9 10325.6 ± 2097.4 405.0 ± 155.0 354.6 ± 125.2 890.5 ± 126.3 
3 Cases 38 324.0 ± 130.6 0.817 10411.9 ± 1478.5 0.468 384.1 ± 172.8 0.943 349.7 ± 145.5 0.866 915.6 ± 152.6 0.747 Controls 36 312.0 ± 130.7 10698.3 ± 1730.2 380.9 ± 158.9 343.0 ± 138.0 903.2 ± 164.0 
4 Cases 18 320.9 ± 89.6 0.740 10867.4 ± 1556.7 0.883 370.6 ± 143.7 0.660 334.3 ± 111.4 0.582 916.5 ± 128.3 0.879 Controls 17 311.7 ± 65.2 10810.4 ± 949.0 389.6 ± 107.4 353.1 ± 86.1 924.8 ± 147.1 
Suckle reflex 
1 Cases 34 296.0 ± 133.1 0.743 10608.8 ± 1787.2 0.961 348.2 ± 176.3 0.555 310.3 ± 137.9 0.568 908.0 ± 144.6 0.556 Controls 34 309.1 ± 90.3 10680.8 ± 2137.2 382.2 ± 136.1 340.0 ± 105.9 887.4 ± 145.1 
2 Cases 37 323.3 ± 120.7 0.915 10337.6 ± 1540.6 0.664 378.6 ± 149.3 0.687 345.3 ± 134.0 0.762 921.2 ± 136.4 0.857 Controls 34 330.8 ± 130.1 10473.0 ± 1476.0 404.2 ± 179.5 363.7 ± 154.5 927.0 ± 154.0 
3 Cases 17 316.9 ± 84.3 0.573 10723.6 ± 1285.4 0.836 377.2 ± 143.3 0.872 341.2 ± 124.0 0.645 880.4 ± 142.1 0.883 Controls 17 297.5 ± 120.4 10624.5 ± 1431.9 371.2 ± 102.8 326.2 ± 90.5 887.0 ± 128.0 
Rectal temperature (°C) 
1 Cases 32 320.5 ± 94.1 0.975 10766.2 ± 1340.5 0.696 394.2 ± 136.5 0.764 351.2 ± 115.5 0.910 914.3 ± 140.2 0.474 Controls 30 321.2 ± 91.2 10969.4 ± 2047.8 387.0 ± 121.5 352.4 ± 103.6 888.7 ± 151.8 
2 Cases 42 301.5 ± 133.5 0.677 10426.5 ± 1862.5 0.799 345.4 ± 175.8 0.408 317.7 ± 147.8 0.640 910.7 ± 152.3 0.415 Controls 41 320.6 ± 125.8 10337.5 ± 1495.6 398.5 ± 178.6 344.5 ± 144.1 932.8 ± 130.4 
3 
Cases 14 321.1 ± 131.2 
0.458 
10218.6 ± 1176.0 
0.798 
367.0 ± 148.9 
0.946 
324.7 ± 127.9 
0.905 
886.8 ± 101.6 
0.552 
Controls 14 286.1 ± 124.8 10365.2 ± 1623.5 365.2 ± 119.0 340.0 ± 120.8 851.3 ± 162.4 
DIM, days in milk; AFC, age at first calving; d, days; SD, standard deviation. 
1vigor class 1 and dehydration class 1 have no cases. 
 
Table 5. Results of generalized linear model for association between laboratory findings and 
variables of interest (DIM, 305-day milk yield, milk fat and protein production, and AFC) in 88 
surviving calves with neonatal calf diarrhea treated with a standard veterinary hospital protocol and 
85 non-affected controls. 
Laboratory findings n. DIM ± SD (d) P 
305-d milk yield ± 
SD (kg) P 
Milk fat ± SD 
(kg) P 
Milk protein ± 
SD (kg) P AFC ± SD (d) P 
Serum total protein (g/L) ≤55 Cases 37 310.4 ± 128.1 0.690 10662.4 ± 1486.3 0.327 367.7 ± 165.7 0.342 321.4 ± 128.9 0.338 914.0 ± 149.9 0.392 Controls 35 326.8 ± 115.4 11125.1 ± 2148.3 430.3 ± 171.5 372.9± 139.2 880.7± 131.6 
>55 Cases 51 278.9 ± 121.0 0.883 10680.3 ± 1785.9 0.918 332.8 ± 161.9 0.721 301.2 ± 136.2 0.706 874.8 ± 121.9 0.856 Controls 50 288.4 ± 124.7 10604.1 ± 1545.5 351.0 ± 142.7 319.1 ± 132.1 886.7 ± 167.8 
pH ≤7.19 Cases 48 323.8 ± 110.9 0.989 10577.8 ± 1566.3 0.865 379.8 ± 157.2 0.564 344.5 ± 133.6 0.664 917.5 ± 156.1 0.292 Controls 47 323.3 ± 111.1 10533.8 ± 1964.1 392.6 ± 137.5 355.7 ± 119.0 885.2 ± 150.3 
7.20-7.34 Cases 33 295.4 ± 138.6  0.696 10288.3 ± 1632.0 0.331 347.1 ± 168.5 0.424 314.1 ± 141.6 0.569 898.4 ± 119.0 0.322 Controls 32 308.1 ± 122.8 10646.1 ± 1362.4 380.7 ± 163.9 335,7 ± 138.5 927.6 ± 146.8 
7.35-7.45 Cases 7 303.4 ± 67.7 0.726 11177.1 ± 1527.9 0.623 367.7 ± 118.8 0.546 318.6 ± 85.3 0.568 890.7 ± 125.4 0.628 Controls 6 295.0 ± 71,9 10690.0 ± 2163.8 404.2 ± 104.5 348.0 ± 104.8 913.8 ± 83.3 
Blood bicarbonate (mmol/L) 
<10 Cases 23 317.9 ± 102.9 0.560 11174.4 ± 1513.1 0.360 380.3 ± 148.7 0.514 353.9 ± 138.5 0.433 896.2 ± 142.3 0.841 Controls 20 295.8 ± 80.3 10761.3 ± 2349.9 345.9 ± 110.2 317.5 ± 87.2 898.8 ± 124.8 
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10-20 Cases 47 304.8 ± 131.4 0.685 10360.3 ± 1328.2 0.302 353.4 ± 167.2 0.277 317.7 ± 135.8 0.306 918.8 ± 152.0 0.499 Controls 47 323.2 ± 131.7 10697.3 ± 1576.6 408.5 ± 166.3 361.4 ± 143.2 896.9 ± 164.5 
>20 Cases 18 329.7 ± 97.1 0.697 10560.2 ± 1317.2 0.173 400.3 ± 133.7 0.652 353.0 ± 105.3 0.577 891.4 ± 113.5 0.360 Controls 18 319.5 ± 92.1 9968.3 ± 1330.7 391.3 ± 136.8 342.7 ± 110.1 922.9 ± 118.6 
Partial pressure of carbon dioxide (mmHg) 
<35 Cases 25 289.6 ± 129.7 0.940 11117.8 ± 1274.8 0.830 347.1 ± 170.7 0.655 322.4 ± 155.6 0.779 907.9 ± 144.1 0.628 Controls 25 290.1 ± 117.6 11129.0 ± 2050.8 374.7 ± 175.5 336.0 ± 149.4 893.0 ± 132.5 
35-50 Cases 46 307.6 ± 110.8 0.786 10592.0 ± 1365.5 0.548 367.5 ± 146.9 0.561 329.9 ± 119.5 0.711 876.4 ± 125.8 0.592 Controls 45 317.8 ± 113.6 10407.1 ± 1603.6 390.7 ± 140.7 342.8 ± 113.6 894.4 ± 153.8 
>50 Cases 17 369.7 ± 105.4 0.467 9766.9 ± 1364.4 0.270 414.6 ± 158.3 0.779 365.6 ± 120.8 0.802 1002.6 ± 148.6 0.359 Controls 14 350.8 ± 100.8 10257.8 ± 1607.9 404.7 ± 137.1 378.8 ± 120.1 946.0 ± 146.7 
Base excess (mmol/L) 
<-5 Cases 71 309.2 ± 120.4 0.783 10601.2 ± 1413.1 0.624 362.3 ± 159.6 0.439 329.5 ± 134.9 0.546 908.2 ± 146.6 0.830 Controls 69 318.3 ± 117.7 10732.1 ± 1773.2 392.4 ± 155.4 350.2 ± 129.0 902.9 ± 143.3 
-5/+5 Cases 15 343.8 ± 102.9 0.416 10728.6 ± 1429.9 0.193 423.0 ± 125.9 0.455 367.0 ± 101.5 0.669 891.1 ± 112.0 0.747 Controls 14 316.4 ± 56.5  9960.2 ± 1594.4 390.4 ± 80,9 350.8 ± 74.7 873.7 ± 141.7 
>-5 Cases 2 256.0 ± 117.4 0.802 9760.0 ± 367.7 0.208 288.5 ± 190.2 0.898 277.5 ± 163.7 0.738 991.0 ± 168.3 0.438 Controls 2 213.5 ± 202.9 9200.0 ± 777.8 259.0 ± 264.4 206.5 ± 210.0 1091.5 ± 194.4 
Blood sodium (mmol/L) 
<130 Cases 68 305.9 ± 122.1 0.704 10589.9 ± 1399.9 0.461 359.3 ± 158.3 0.496 325.4 ± 137.5 0.589 921.6 ± 150.1 0.707 Controls 65 319.6 ± 121.6 10409.4 ± 1797.8 390.9 ± 156.1 348.0 ± 133.0 911.8 ± 151.3 
130-150 Cases 17 335.6 ± 109.0 0.381 10722.8 ± 1485.2 0.585 400.6 ± 158.3 0.794 358.2 ± 110.6 0.674 865.5 ± 98.4 0.693 Controls 17 301.0 ± 81.8 10900.8 ± 1517.5 382.6 ± 123.9 334.7 ± 97.4 886.2 ± 129.6 
>150 Cases 3 347.00 ± 15.9 0.098 10153.0 ± 1128.4 0.106 425.3 ± 25.0 0.300 383.7 ± 20.2 0.301 838.0 ± 106.2 0.146 Controls 3 322.7 ± 104.4 11183.3 ± 585.0 418.7 ± 193.1 385.7 ± 132.8 879.3 ± 129.5 
Blood chloride (mmol/L) 
<97 Cases 6 388.7 ± 124.3 0.128 10434.8 ± 950.9.1 0.220 442.5 ± 154.9 0.252 336.3 ± 96.0 0.833 926.8 ± 127.3 0.756 Controls 6 320.5 ± 45.5 9535.5 ± 1504.5 371.0 ± 55.4 341.0 ± 30.6 905.3 ± 115.5 
97-110 Cases 64 304.7 ± 124.1 0.745 10475.7 ± 1410.6 0.922 357.8 ± 163.3 0.427 310.4 ± 137.0 0.494 920.2 ± 151.2 0.605 Controls 62 316.8 ± 118.5 10447.9 ± 1791.1 393.1 ± 156.8 334.9 ± 129.5 905.3 ± 155.9 
>110 Cases 16 319.0 ± 76.6 0.872 11164.0 ± 1413.5 0.980 390.7 ± 119.9 0.952 365.1 ± 99.2 0.837 849.9 ± 86.8 0.098 Controls 15 313.2 ± 119.1 11152.3 ± 1381.8 387.6 ± 154.7 356.1 ± 139.5 909.1 ± 123.0 
Blood potassium (mmol/L) 
<3.9 Cases 6 276.5 ± 144.2 0.958 9830.8 ± 669.3 0.305 291.2 ± 167.4 0.782 273.3 ± 158.0 0.700 973.3 ± 108.0 0.000 Controls 6 282.8 ± 154.9 9870.0 ± 1579.2 317.3 ± 200.8 296.0 ± 184.5 866.6 ± 316.7 
3.9-5.8 Cases 33 280.8 ± 116.2 0.776 10807.1 ± 1274.8 0.952 337.6 ± 157.4 0.769 303.4 ± 127.6 0.530 908.9 ± 131.2 0.468 Controls 33 296.2 ± 135.6 10477.8 ± 2070.1 383.6 ± 184.9 331.4 ± 150.5 900.4 ± 116.2 
>5.8 Cases 49 340.7 ± 110.4 0.809 10554.4 ± 1523.6 0.403 402.4 ± 148.1 0.853 363.1 ± 124.1 0.790 898.2 ± 151.9 0.412 Controls 46 334.3 ± 89.4 10644.4 ± 1488.2 404.5 ± 113.7 364.0 ± 96.7 915.0 ± 135.2 
Anion gap (mmol/L) 
<8 Cases 5 285.6 ± 72.4 0.723 10631.5 ± 1326.9 0.560 351.6 ± 129.5 0.706 310.6 ± 99.6 0.827 876.4 ± 150.1 0.731 Controls 5 324.8 ± 156.2 10254.0 ± 913.1 416.6 ± 230.4 341.8 ± 183.5 909.0 ± 195.1 
8-16 
Cases 27 319.1 ± 141.4 
0.972 
10676.6 ± 1345.5 
0.316 
384.4 ± 171.0 
0.966 
341.0 ± 144.6  
0.931 
932.1 ± 149.5 
0.510 
Controls 26 321.1 ± 99.9 10283.5 ± 1447.9 387.6 ± 132.2 346.7 ± 110.4 900.6 ± 167.2 
>16 Cases 56 310.2 ± 112.1 0.941 10429.7 ± 1727.9 0.488 359.3 ± 155.8 0.504 328.0 ± 131.8 0.622 899.5 ± 135.3 0.764 Controls 53 312.8 ± 177.4 10703.0 ± 1888.5 387.1 ± 152.7 346.8 ± 129.3 907.1 ± 131.3 
Microhematocrit (%)1 
18-30 Cases 28 310.5 ± 112.6 0.485 10413.9 ± 1135.6 0.775 381.4 ± 160.9 0.558 332.2 ± 134.9 0.628 895.4 ± 149.4 0.773 Controls 25 268.7 ± 116.4 10540.4 ± 2259.2 333.8 ± 156.9 297.1 ± 137.7 881.4 ± 173.6 
>30 
Cases 60 315.9 ± 120.2 
0.540 
10684.4 ± 1491.2 
0.562 
365.4 ± 153.4 
0.154 
335.5 ± 128.7 
0.266 
913.6 ± 137.5 
0.940 Controls 60 334.6 ± 108.5 10520.7 ± 1494.4 412.1 ± 143.1 366.0 ± 117.2 915.5 ± 134.1 
DIM, days in milk; AFC, age at first calving; d, days; SD, standard deviation. 
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Discussion and conclusion  
The passive immunity of calves influences the morbidity and mortality rates during the first month 
of life 1. Calves that do not acquire an adequate amount of colostrum during their first hours of life 
are predisposed to developing neonatal diseases such as NCD, septicemia, arthritis and umbilicus 
diseases2,3. Therefore, the mortality rate is obviously higher in these calves. Use of fresh frozen 
plasma, serum and whole blood are empirically recommended for the treatment of calves with 
ITPI4,5. Furthermore, antimicrobial treatment is suggested for ITPI calves during NCD for the 
high risk of bacteremia6. The direct tests to detect ITPI (IgG less than 10g/L) are RID and ELISA 
tests. These are more accurate, but have higher costs and require time to obtain the results, 
therefore their routine use is not justified, especially in field conditions. Among indirect methods 
to determine the passive immunity, sTP concentration are the most used7. Therefore, the influence 
of diseases on sTP, especially dehydration could affect the results of this test5. Another well-
documented indirect method to estimate IgG and the transfer of passive immunity is the 
determination of gamma glutamyl-transferase (GGT) activity 8-10. This method requires laboratory 
analysis but is cheaper and faster compared to the direct methods. In this study, the influence of 
NCD on the accuracy of sTP test and GGT activity test was investigated. As underlined by our 
study, the sTP concentration is not an accurate method to detect passive immunity in calves with 
NCD, also considering dehydration. The possible explanation of this result is that not only 
dehydration, but also panhypoproteinemia influences sTP concentration. This condition could 
affect calves with diarrhea due to sepsis, protein-losing enteritis, gastrointestinal blood loss, 
disseminated intravascular coagulation and peritonitis, which are closely correlated with NCD 11,12. 
The GGT activity was found to be influenced by age, as already demonstrated in the literature9,10. 
However, they are not affected by NCD. These findings underline the higher ability of GGT 
compared to sTP in evaluating the transfer of passive immunity in calves affected by NCD.  
Therefore, low concentrations of sTP, along with the absence of the suckle reflex, resulted to be a 
fatality risk during NCD. Our findings suggest that ITPI is associated with decreased effectiveness 
of the therapeutic protocol. In addition to ITPI other causes of panhypoproteinemia cannot be 
ruled out. This result may be explained by the fact that panhypoproteinemia is often a consequence 
of NCD including sepsis, protein-losing enteritis, gastro-intestinal blood loss, disseminated 
intravascular coagulation and peritonitis2,12.  
The clinical presentation of NCD is characterized by liquid feces, dehydration, metabolic acidosis, 
alterations in posture, behavior and hypovolemic shock. Therefore, the aim of treatment is to 
correct the hydration and acid-base imbalance with fluid therapy. Antibiotic treatment is 
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commonly recommended regardless of the pathogen involved, particularly in calves with ITPI for 
the high risk of bacteremia, but the real efficacy of its use is controversial. In our project, we also 
investigated the efficiency of antibiotics during NCD and their influence on the gut microbiota, 
considering the immunity status of the calf. The results of this study showed no statistical difference 
in mortality rates, failure of treatment, average daily gain and days with diarrhea between groups 
treated with or without antibiotics, regardless of the presence or absence of ITPI. Furthermore, 
the antibiotic treatment was found to be associated with a worsening of the fecal score and scleral 
vessels. The red, increased sclera vessels were considered a sign of endotoxemic shock. The possible 
explanation of the association showed between sclera vessels and antibiotic treatment in our results 
could be that the use of antibiotics in the case of E. coli infection is detrimental13. 
Lipopolysaccharides (LPS), a component of the cell wall of gram-negative bacteria, are considered 
the primary virulence factor of coliform bacteria14, being responsible for most pathophysiological 
reactions in E. coli sustained diseases15, even endotoxemic shock. LPSs are released from the 
bacteria following cell death caused by antibiotics15,16 and the clinical signs are induced by LPSs as 
the consequence of the release of inflammatory mediators15-17. In our study, the antibiotic had a 
negative influence on the aspect of the feces, with more severe cases of diarrhea in calves treated 
with antimicrobials. This finding was supported by the microbiota results. In fact, the microbiota 
analysis showed that calves treated without antibiotics re-established their microbiota earlier 
compared to calves treated with antibiotics. These findings agree with the literature. The negative 
correlation between antibiotics and dysbiosis was reported in the literature, not only in calves. On 
the other hand, antibiotic treatment can influence the thevre-establishment of the normal 
microbiota, predisposing the calves to relapses18-20.  
Our data suggests that antibiotic treatment should be omitted in cases of NCD. In addition, our 
results found the same mortality rates in calves with ITPI compared to animals with adequate 
transfer of passive immunity. This result is unexpected, but in our study ITPI calves were treated 
with hyperimmune plasma as recommended by the literature. Therefore, we speculated that plasma 
transfusion had influenced the mortality rate and resulted effective in the treatment of ITPI. 
The last study of this project investigates the long-term effect of NCD on production and 
reproduction performance, also considering the clinical severity and laboratory parameters of the 
disease. No effect of NCD on the first performance was found, also considering the severity of the 
clinical presentation. These findings suggest that when treated, NCD had no effect on the age at 
first calving and first lactation production. This would ensure suitable reproductive and production 
standards during the first lactation even in calves that have had severe NCD. In this study, the 
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concentration of sTP was investigated as a parameter that can influence the production and 
reproduction performance. Previous studies have postulated the role of the volume of colostrum 
ingested, and level of passive immunity in future production performance, due to an enhanced 
culling and mortality rate or due to an unspecified growth-promoting activity of the colostrum21,22. 
In contrast with these previous studies, our results show no differences in production and 
reproductive indices in diarrheic calves with an sTP cut-off value of 55 g/L. A possible explanation 
is the absence of long-term effects on the immune system in surviving calves due to the normal 
development of the cellular and humoral immunities which increase gradually during the first 
month of life and mature approximately at six months after birth23. Furthermore, despite its 
frequent use in passive transfer evaluation, the sTP concentration in critically ill calves is still an 
open issue. Especially in diarrheic calves >1 week of age, the causes of hypoproteinemia directly 
correlated with NCD (e.g., protein-losing enteritis, gastro-intestinal blood loss, anorexia) cannot 
be ruled out24 (Boccardo et al., 2017).  
In conclusion, the present project improves the knowledge on the relation between ITPI and NCD. 
In particular, the results of this study add to our knowledge in diagnostic, prognostic, therapy and 
long-term effects regarding the correlation of these two diseases. Based on the results obtained in 
this project, the recommendations emerged are to prefer GGT as a diagnostic method to identify 
ITPI calves during NCD, to omit antibiotic treatments during NCD, and to give more importance 
to fluid therapy. Fluid therapy alone could be sufficient to cure NCD and is also likely to not cause 
any damage in the long term. The sTP concentration results can be representative of the fatality 
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